MARIJUANA COMPANY OF AMERICA INC. (OTC: MCOA)
Breaking News
September 25, 2018
Something for Everyone: Baby
Boomers Signify Shift in the Cannabis Market
New York, NY –
September 25, 2018 –
CannabisNewsWire.com News Coverage:
Since they came onto the scene after World War II, baby boomers have heavily
impacted the world around them, and their influence is being felt now in the
emerging cannabis market.
-
A recent survey has
shown a significant increase in cannabinoid-derived product consumption in
the United States, most notably among baby boomers.
-
With a combination
of disposable income, health issues and liberal attitudes towards drugs,
baby boomers represent a natural market for cannabis companies.
-
This trend also
signifies wider growth and diversification of products and customers in the
industry.
Marijuana Company of America (OTC:MCOA)
is tapping into this growing market through the production of industrial hemp
and the marketing of a wide range of CBD wellness products. Having started out
as a medical cannabis company, Organigram Holdings, Inc. (OTC:OGRMF) is
adjusting to shifting markets by appealing to recreational consumers while
showing loyalty to its existing customer base. A focus on research provides
CV Sciences, Inc. (OTC:CVSI) with a growing range of products and the
credibility to appeal to health-conscious cannabis consumers. Global innovator
and market leader Isodiol International, Inc. (OTC:ISOLF) recently
received approval for its cannabidiol (CBD) to be designated as an active
pharmaceutical ingredient. And Cannabis Strategic Ventures (OTC:NUGS)
just launched a new line of CBD-based luxury skin, hair and body products.
To view an infographic of this editorial,
click here.
The Changing Face of Cannabis
It’s hardly surprising to see that baby boomers are an important part of the
cannabis and hemp markets. The generation that saw marijuana gain
counter-culture popularity in the ‘60s and ‘70s is also a generation with
considerable disposable income. As they head into retirement and old age, many
baby boomers are looking for ways to enjoy their wealth, as well as ways to
manage physical ailments. The growth of both the medical and the recreational
cannabis sectors in North America means that this product can cater to both
desires.
The growth in cannabinoid consumption by baby boomers is just part of the
expansion of the cannabis market. Given the chance to openly research plant and
products, manufacturers are vastly increasing the potential of cannabis.
Improved strains improve the performance and profitability of the drug, while
derivative products and support services turn what was essentially a single
product into a whole sector.
Baby Boomers and Cannabis
Consumption
For companies such as
Marijuana Company of America (OTC: MCOA), baby boomers are an
increasingly important market sector. A recent survey of nearly 18,000 adult
Americans found that
cannabis is becoming increasingly popular among the older generation. The
number of cannabis users in the United States has nearly doubled over the past
decade, despite it still being illegal in several states and only available for
medical use in most. Around 9 percent of those aged 50 to 64 had used cannabis
at some point in the year preceding the survey. Among those aged 65 and above,
the figure was 3 percent. And while those numbers may not seem impressive, they
are steadily growing and represent an increasingly large market for MCOA and its
competitors to tap into.
What’s causing this growth in older cannabis users?
Shifting attitudes are clearly a factor. Many baby boomers came of age in the
‘60s and ‘70s, when the hippy movement raised the public profile and popularity
of cannabis. They were therefore raised with marijuana as a feature of popular
culture, even if they personally didn’t indulge in it. More recently, a shift
away from the criminalizing policies of the 1980 s towards a more liberal view
has started to change attitudes across the generations.
Growing availability is a factor as well. The legalization of medical cannabis
in many states has made the drug accessible in ways that it wasn’t before. Given
the prevalence of chronic pains and ongoing ailments among those aged 60 and
over, it’s relatively easy for seniors in medical cannabis states to get a
prescription. And in the states where it’s legal for recreational purposes, the
only bar to use is the social attitude of the consumer.
Having grown up during an economic boom and an era with greater government
support, baby boomers have emerged with the wealth to enjoy their hobbies in
retirement. And for many, cannabis is now one of those hobbies.
Something for Everyone
Baby boomers are just one part of recent growth in the cannabinoid product
market. It’s a pattern of growth driven in part by the increasing diversity of
cannabis products, sold through separate but interconnected markets.
The first to emerge was the medical cannabis sector. This has grown from a small
niche to an important part of the North America market, with cannabis and hemp
now legal in parts of the United States and Canada. Millions of people use
cannabinoid-based products regularly to help manage chronic pain and treat other
ailments, leading to growing recognition that the legal definition of cannabis
as having no medical use was both absurd and unscientific.
Medical cannabis has been followed in recent years by the legalization of
recreational cannabis. Nine U.S. states and the District of Columbia have taken
this step. Canada is following suit on a national level, with legalization
coming this October. Strains of cannabis and brands of products aimed at
recreational consumers are emerging to cater to a different market from the
medical one.
Alongside these products are others related to or derived from other
cannabinoids, such as CBD. Industrial hemp, which produces CBD in large
quantities, is grown by companies including MCOA, who has the potential to
capture a piece of what is projected by The Brightfield Group to be a $22
billion market by 2022. Following trials over the past few years, the
cultivation of industrial hemp looks set to become legal across the United
States with the upcoming passage of the 2018 Farm Bill.
A wide range of products have been produced using active compounds from hemp.
Oils and pills derived from cannabidiol oil (CBD) are increasingly popular in
the health and wellness markets, finding their place on the shelves of wholefood
shops.
Catering to Varied Needs
One of the reasons for the success of cannabis companies is their ability to
manufacture and distribute CBD-related products for vastly different purposes.
MCOA’s hempSMART™ product line shows how these companies build up a range of
distinct but related products. hempSMART makes use of cannabidiol (CBD), a
non-psychoactive chemical found in cannabis and widely used in health and
wellness products.
HempSMART Pain and
hempSMART Pain Cream use CBD for one of cannabis’s most widely recognized
uses — pain management in relation to minor physical activity. It’s why cannabis
had grown so popular and part of why its derivatives are also proving so popular
with a variety of different age groups.
HempSMART Brain, on the other hand, is designed to improve clarity,
concentration and alertness.
HempSMART Face has found a way to use CBD in a moisturizer that moisturizes
and replenishes the skin cells on your face. And
hempSMART Pet Drops let people share the benefits of CBD with their animal
companions. It’s a level of variety that may allow MCOA to get its products into
many niches, increasing brand awareness as well as sales.
By creating a wide range of products, cannabis companies are catering to a
growing number of markets. By helping with issues such as alertness and pain
management, they’re ensuring their relevance to that crucial baby boomer market.
Expanding the Range of Cannabis Products
That sort of varied approach to cannabis is leading to growth for Organigram
Holdings, Inc. (OTCQX:OGRMF). Once a medical cannabis company, Organigram
still has a strong focus on that market and is showing its commitment to
patients by
covering the cost of excise tax on their cannabis. But it’s also expanding
into the recreational market,
contributing one of its award-winning flowers to the world’s first recreational
cannabis variety kit. Creating products such as variety kits and gift sets
turns cannabis into more of a luxury consumer product, one to be purchased for
special occasions.
CV Sciences, Inc. (OTCQB:CVSI) is strongly focused on the research side
of cannabis, using this as both a source of new products and a way of validating
its work to consumers. It’s the sort of work that adds credibility to arguments
that cannabis is safe and useful for consumers.
Isodiol International, Inc. (OTCQB:ISOLF) is a market leader in
pharmaceutical-grade pure, natural CBD and an industry leader in the
manufacturing and development of CBD consumer products. The company’s line of
consumable and topical skin care products features 99 percent-plus pure, natural
isolated CBD, micro-encapsulations, and nano-technology for the highest quality
products.
Cannabis Strategic Ventures (OTC:NUGS)
is marrying cannabis science with an increasing global demand for luxury
personal care products in LYXR, its newest product line. LYXR products are
developed from a line of hemp-derived phytocannabinoids combined with other
natural ingredients that provide high-performing skin, hair and body topical
solutions. LYXR’s inaugural product will be a face mask designed to provide
hydrating and anti-aging/age prevention benefits. The LYXR product line will
eventually include skin, hair and body products.
The cannabis market is seeing huge growth in the variety of both products and
customers. With baby boomers increasingly enjoying cannabis into retirement,
marijuana appears to be well on its way to entering the mainstream.
For more information about MCOA, please visit
Marijuana Company of America (OTC: MCOA).
About CannabisNewsWire
CannabisNewsWire (CNW) is an information service that provides (1) access to our
news aggregation and syndication servers, (2)
CannabisNewsBreaks
that summarize corporate news and information, (3) enhanced press release
services, (4) social media distribution and optimization services, and (5) a
full array of corporate communication solutions. As a multifaceted financial
news and content distribution company with an extensive team of contributing
journalists and writers, CNW is uniquely positioned to best serve private and
public companies that desire to reach a wide audience of investors, consumers,
journalists and the general public. CNW has an ever-growing distribution network
of more than 5,000 key syndication outlets across the country. By cutting
through the overload of information in today’s market, CNW brings its clients
unparalleled visibility, recognition and brand awareness. CNW is where news,
content and information converge.
Receive Text Alerts from
CannabisNewsWire:
Text "Cannabis" to
21000
For more
information please visit
https://www.CannabisNewsWire.com
and or
https://CannabisNewsWire.News
Please see
full terms of use and disclaimers on the CannabisNewsWire website applicable to
all content provided by CNW, wherever published or re-published:
http://CNW.fm/Disclaimer
DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set
forth above. References to any issuer other than the profiled issuer are
intended solely to identify industry participants and do not constitute an
endorsement of any issuer and do not constitute a comparison to the profiled
issuer. FN Media Group (FNM) is a third-party publisher and news dissemination
service provider, which disseminates electronic information through multiple
online media channels. FNM is NOT affiliated with CNW or any company mentioned
herein. The commentary, views and opinions expressed in this release by CNW are
solely those of CNW and are not shared by and do not reflect in any manner the
views or opinions of FNM. Readers of this Article and content agree that they
cannot and will not seek to hold liable CNW and FNM for any investment decisions
by their readers or subscribers. CNW and FNM and their respective affiliated
companies are a news dissemination and financial marketing solutions provider
and are NOT registered broker-dealers/analysts/investment advisers, hold no
investment licenses and may NOT sell, offer to sell or offer to buy any
security.
The Article and content related to the profiled company represent the personal
and subjective views of the Author, and are subject to change at any time
without notice. The information provided in the Article and the content has been
obtained from sources which the Author believes to be reliable. However, the
Author has not independently verified or otherwise investigated all such
information. None of the Author, CNW, FNM, or any of their respective
affiliates, guarantee the accuracy or completeness of any such information. This
Article and content are not, and should not be regarded as investment advice or
as a recommendation regarding any particular security or course of action;
readers are strongly urged to speak with their own investment advisor and review
all of the profiled issuer's filings made with the Securities and Exchange
Commission before making any investment decisions and should understand the
risks associated with an investment in the profiled issuer's securities,
including, but not limited to, the complete loss of your investment.
CNW & FNM HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains "forward-looking statements" within the meaning of Section
27A of the Securities Act of 1933, as amended, and Section 21E the Securities
Exchange Act of 1934, as amended and such forward-looking statements are made
pursuant to the safe harbor provisions of the Private Securities Litigation
Reform Act of 1995. "Forward-looking statements" describe future expectations,
plans, results, or strategies and are generally preceded by words such as "may",
"future", "plan" or "planned", "will" or "should", "expected," "anticipates",
"draft", "eventually" or "projected". You are cautioned that such statements are
subject to a multitude of risks and uncertainties that could cause future
circumstances, events, or results to differ materially from those projected in
the forward-looking statements, including the risks that actual results may
differ materially from those projected in the forward-looking statements as a
result of various factors, and other risks identified in a company's annual
report on Form 10-K or 10-KSB and other filings made by such company with the
Securities and Exchange Commission. You should consider these factors in
evaluating the forward-looking statements included herein, and not place undue
reliance on such statements. The forward-looking statements in this release are
made as of the date hereof and CNW and FNM undertake no obligation to update
such statements.
CannabisNewsWire (CNW) & NetworkNewsWire (NNW) are proud to be affiliated
partners of the Investor Brand Network (IBN)
About IBN
Over the past 10+ years we have consistently introduced new network brands,
each specifically designed to fulfil the unique needs of our growing client base
and services. Today, we continue to expand our branded network of highly
influential properties, leveraging the knowledge and energy of specialized teams
of experts to serve our increasingly diversified list of clients.
Please feel free to visit the Investor Brand Network (IBN)
http://www.InvestorBrandNetwork.com
Corporate Communications
Contact:CannabisNewsWire
(CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net
Media Contact:
FN Media Group, LLC
NNW@FinancialNewsMedia.com
+1-(954)345-0611
News Source: CannabisNewsWire
Canadian Cannabis Legalization
Set to Transform the Industrial Hemp Industry
New York, NY –
September 19, 2018 –
CannabisNewsWire.com News Coverage:
The legalization of cannabis in Canada is about to bring big changes not just
for medical cannabis companies but for hemp growers as well.
-
The law legalizing
recreational cannabis in Canada will come into force on October 17.
-
This will create new
opportunities for hemp growers to produce the plant for CBD extraction.
-
Hemp growers will
now be able to profit from all parts of the plant.
-
Cannabis companies
are experimenting with growing techniques, expanding their businesses, and
seeking supply agreements in preparation for the change.
Marijuana Company of America (OTC:MCOA),
which grows industrial hemp in Canada, will now be able to sell leaves and
flowers as well as other parts of its plants, and is preserving this year’s crop
in preparation for the change. In the United States, Isodiol International,
Inc. (OTC:ISOLF) is raising the profile of the industry through a celebrity
partnership and the expansion of its retail chain. Aurora Cannabis, Inc.
(OTC:ACBFF) has been acquiring financing to fund a program of expansions and
takeovers, preparing the way to dominate the American market. Organigram
Holdings, Inc. (OTC:OGRMF) and Emerald Health Therapeutics (OTC:EMHTF)
have both set up a string of supply agreements, giving them quick access to the
Canadian recreational market come October.
To view an infographic of this
editorial,
click here.
Transforming Canada’s Cannabis Industry
On October 17, cannabis will become legal in Canada. Under
the provisions of the Cannabis Act, Canadians will be able to buy and consume
cannabis for recreational as well as medical purposes. Careful licensing,
together with clear rules around cultivation and processing, will ensure that a
previously illegal industry becomes a well-regulated part of the legal economy.
As Prime Minister Trudeau said when the law was passed, “It’s been too easy for
our kids to get marijuana — and for criminals to reap the profits. Today, we
change that.”
The Cannabis Act promises to be a great boon to the
Canadian economy. Since 2014, the Canadian medical cannabis industry has
grown to include over 100 licensed companies, many of which will be able to
expand their sales and research under the new rules. In a year’s time,
further rules will come into force that allow the sale of concentrates and
edible cannabis products, creating a cannabis food and drink industry. But one
of the biggest changes will take place within the industrial hemp industry.
Cannabis without the High
While the term “cannabis” is most often used to refer to
plants with psychoactive effects, it actually covers a broader range of crops.
One of the most historically prevalent varieties of cannabis is industrial hemp,
a form of cannabis grown by companies such as the
Marijuana Company of America (OTC:MCOA).
Industrial hemp is distinct from more controversial forms
of cannabis — marijuana — in that it does not contain tetrahydrocannabinol
(THC), the active ingredient that gets users high, but rather it contains
cannabidiol (CBD), which has recently grown in popularity due to its variety of
medicinal benefits. Hemp was used for hundreds of years to produce fibers for
cloth and rope and was widely grown in North America. But for most of the past
century, it has been out of production thanks to broad-ranging anti-cannabis
legislation.
The past few years have seen a resurgence for industrial
hemp. Legislation created for the cultivation of medical marijuana has created
the opportunity for companies such as MCOA to grow hemp in Canada. In the United
States, the 2014 Farm Bill created legal space for trial crops of hemp. That
bill’s 2018 successor appears set to make it
entirely legal in the United States, allowing farmers to grow a highly
profitable new crop.
The passing of the Cannabis Act will further improve the
potential of hemp in Canada, as it will
allow producers to extract cannabidiol (CBD). Cannabidiol is an active
ingredient that’s commonly found in high concentrations in certain varieties of
industrial hemp. It doesn’t have the psychoactive properties of THC but has been
shown to have beneficial effects on health. As a result, it’s used in a
growing variety of health and wellness products, including MCOA’s brand
hempSMARTTM.
Using the Whole Plant
Up until now, Canadian hemp producers have been
limited in what they can do with the plant. The seeds could be extracted and
used; fibers could be turned into textiles; and leftover elements known as hurds
could be turned into either animal feed or construction materials. The use of
leaves and flowers was specifically prohibited.
The Cannabis Act allows for a broader range of uses.
Health Canada has proposed the introduction of new industrial hemp licenses
to make this a reality. Under the proposed system, industrial hemp producers
will be able to sell the whole plant or any of its parts to other licensed
operators within the hemp industry. They could even process it themselves,
extracting CBD oil as well as seeds, fibers and hurds.
It’s a change that will create a more efficient and
profitable industry, as parts of the plant will no longer go to waste. And
growing interest in CBD as a wellness ingredient could lead to a significant
rise in income for hemp farmers. Companies such as MCOA, whose operations cover
the whole industrial chain from hemp production to the sale of CBD products,
will be able to build solid, sustainable supply chains that maximize profits at
every step.
This is all before taking into account the
possibility of agricultural subsidies. There is currently disagreement
within Canada over whether cannabis growers will be eligible for subsidies under
existing rules, but with the arrival of cannabis-based foods and beverages next
year, lines will become increasingly blurry. MCOA and its joint venture partner,
Global Hemp Group Inc., have received financial support from Canadian government
agencies to research hemp cultivation. As the commercial landscape changes, hemp
producers may soon find themselves eligible for even more government help.
Sowing the Seeds for a Growing Industry
MCOA’s growth in the Canadian hemp sector comes through its
establishment of a high-yielding CBD hemp cultivation project in New Brunswick
(NB). This collaboration with Global Hemp Group has revived hemp cultivation in
the region 20 years after a previous effort failed.
The joint venture partners are in process of completion of
the first phase of what is known as the Hemp Agro-Industrial Zone, or HAIZ. The
aim of the HAIZ is to provide a steady supply of hemp by building a local
industrial cluster, guaranteeing a market for farmers and leading to year-round
jobs for others in the region. Through trial crops and careful measurement of
the results, the project is providing valuable data on important issues such as
pests, fertilizers and growth rates.
Recent developments at the site include the
installation of drying equipment in preparation for processing. In the short
term, this will allow the company to effectively store its current harvest until
it can be sold and processed under the rules coming in October. In the longer
term, it will increase its options for growing, processing and selling hemp. The
joint venture partners are currently in the process of negotiating off-take
agreements with extraction companies to sell the biomass produced during the
October harvest in New Brunswick.
MCOA and its partners in New Brunswick have been finding
ingenious ways to improve techniques impeded by decades outside the law. This
year, the team in NB experimented with a modified bean harvester to strip leaves
and flowers from the plants without picking up much straw. Based on the results,
this technique is being extended to the entire 125-acre project.
Cannabis Cultivation Creates New Industry
In less than two decades, a whole new industry has grown up
around the cultivation of hemp and other forms of cannabis. Even with
restrictions still tight in much of the world, companies are finding ways to
legally profit from these crops.
Isodiol International, Inc. (OTCQB:ISOLF) has become
an important and active voice for the industry,
employing former NFL player Marvin Washington as a director and spokesperson.
The company has developed a variety of cannabis and CBD-derived products,
tapping into the medical and vaping markets. Its KURE Corp subsidiary provides a
strong retail front and has recently set its sights on further expansion through
new and acquired shops.
A prominent player within the industry, Aurora Cannabis,
Inc. (OTCQX:ACBFF) is making the most of a young market to rapidly expand
its business. A $150 million loan from the Bank of Montreal is giving it a
short-term financial boost to get ahead of the long-term game. It’s this sort of
long-term thinking that has led the company to acquisitions such as the
takeover of MedReleaf, increasing Aurora’s market share. Some commentators
have compared this strategy with that of Amazon, focusing on market dominance as
the route to profit.
Organigram Holdings, Inc. (OTCQX:OGRMF), a medical
cannabis company, is preparing to expand into Canada’s recreational market in
October. The company has established a number of agreements with other
companies, most recently the Nova Scotia Liquor Corporation, to supply its
products to stores. These agreements will ensure that the legal recreational
market quickly grows from a principle to a reality.
Emerald Health Therapeutics (OTCQX:EMHTF) is also
setting up supplier agreements to give it a place in the recreational starting
lineup. Its partners include the Newfoundland Labrador Liquor Corporation and
Ontario Cannabis Retail Corporation.
The Canadian cannabis industry is set to experience a
transformation on October 17, one that will prepare companies to expand as laws
change elsewhere in the world. From medical cannabis companies to hemp growers,
many business enterprises are likely to profit from this change.
For more information about MCOA, please visit
Marijuana Company of America (OTC:MCOA).
About CannabisNewsWire - CannabisNewsWire (CNW) is an
information service that provides (1) access to our news aggregation and
syndication servers, (2)
CannabisNewsBreaks that summarize corporate news and information,
(3) enhanced press release services, (4) social media distribution and
optimization services, and (5) a full array of corporate communication
solutions. As a multifaceted financial news and content distribution company
with an extensive team of contributing journalists and writers, CNW is uniquely
positioned to best serve private and public companies that desire to reach a
wide audience of investors, consumers, journalists and the general public. CNW
has an ever-growing distribution network of more than 5,000 key syndication
outlets across the country. By cutting through the overload of information in
today’s market, CNW brings its clients unparalleled visibility, recognition and
brand awareness. CNW is where news, content and information converge.
Receive Text Alerts from CannabisNewsWire:
Text "Cannabis" to 21000
For more information please visit
https://www.CannabisNewsWire.com
and or
https://CannabisNewsWire.News
Please see full terms of use and disclaimers on the CannabisNewsWire website
applicable to all content provided by CNW, wherever published or re-published:
http://CNW.fm/Disclaimer
DISCLAIMER:
CannabisNewsWire (CNW) is the source of the Article and content set forth above.
References to any issuer other than the profiled issuer are intended solely to
identify industry participants and do not constitute an endorsement of any
issuer and do not constitute a comparison to the profiled issuer. FN Media Group
(FNM) is a third-party publisher and news dissemination service provider, which
disseminates electronic information through multiple online media channels. FNM
is NOT affiliated with CNW or any company mentioned herein. The commentary,
views and opinions expressed in this release by CNW are solely those of CNW and
are not shared by and do not reflect in any manner the views or opinions of FNM.
Readers of this Article and content agree that they cannot and will not seek to
hold liable CNW and FNM for any investment decisions by their readers or
subscribers. CNW and FNM and their respective affiliated companies are a news
dissemination and financial marketing solutions provider and are NOT registered
broker-dealers/analysts/investment advisers, hold no investment licenses and may
NOT sell, offer to sell or offer to buy any security.
The Article and content related to the profiled company represent
the personal and subjective views of the Author, and are subject to change at
any time without notice. The information provided in the Article and the content
has been obtained from sources which the Author believes to be reliable.
However, the Author has not independently verified or otherwise investigated all
such information. None of the Author, CNW, FNM, or any of their respective
affiliates, guarantee the accuracy or completeness of any such information. This
Article and content are not, and should not be regarded as investment advice or
as a recommendation regarding any particular security or course of action;
readers are strongly urged to speak with their own investment advisor and review
all of the profiled issuer's filings made with the Securities and Exchange
Commission before making any investment decisions and should understand the
risks associated with an investment in the profiled issuer's securities,
including, but not limited to, the complete loss of your investment.
CNW & FNM HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains "forward-looking statements" within the
meaning of Section 27A of the Securities Act of 1933, as amended, and Section
21E the Securities Exchange Act of 1934, as amended and such forward-looking
statements are made pursuant to the safe harbor provisions of the Private
Securities Litigation Reform Act of 1995. "Forward-looking statements" describe
future expectations, plans, results, or strategies and are generally preceded by
words such as "may", "future", "plan" or "planned", "will" or "should",
"expected," "anticipates", "draft", "eventually" or "projected". You are
cautioned that such statements are subject to a multitude of risks and
uncertainties that could cause future circumstances, events, or results to
differ materially from those projected in the forward-looking statements,
including the risks that actual results may differ materially from those
projected in the forward-looking statements as a result of various factors, and
other risks identified in a company's annual report on Form 10-K or 10-KSB and
other filings made by such company with the Securities and Exchange Commission.
You should consider these factors in evaluating the forward-looking statements
included herein, and not place undue reliance on such statements. The
forward-looking statements in this release are made as of the date hereof and
CNW and FNM undertake no obligation to update such statements.
CannabisNewsWire (CNW) & NetworkNewsWire (NNW) are proud to be affiliated
partners of the Investor Brand Network (IBN)
About IBN
Over the past
10+ years we have consistently introduced new network brands, each specifically
designed to fulfil the unique needs of our growing client base and services.
Today, we continue to expand our branded network of highly influential
properties, leveraging the knowledge and energy of specialized teams of experts
to serve our increasingly diversified list of clients.
Please feel
free to visit the Investor Brand Network (IBN)
http://www.InvestorBrandNetwork.com
Corporate
Communications Contact:
CannabisNewsWire (CNW)
Denver,
Colorado
www.CannabisNewsWire.com
303.498.7722
Office
Editor@CannabisNewsWire.net
Media Contact:
FN Media Group,
LLC
NNW@FinancialNewsMedia.com
+1-(954)345-0611
SOURCE:
CannabisNewsWire
Latest Farm Bill Developments
Hold Out Hope for Hemp Farmers
New York, NY –
September 12, 2018 –
CannabisNewsWire.com News Coverage:
After
years of wrangling, the U.S. Congress stands on the verge of legalizing the
cultivation of industrial hemp.
-
Hemp is a variety of
the cannabis sativa plant that doesn’t generate a psychoactive effect.
-
Traditionally used
to produce cloth and rope, hemp can also now be used in wellness products
and food.
-
Competing
legislations by the House and Senate are being aligned with an anticipated
September 30 deadline.
-
The legalization of
hemp has cross-party support and appears likely to pass.
The expected
change in U.S. law will be beneficial for companies such as
Marijuana
Company of America (OTC:MCOA),
which is already invested in industrial hemp and support for hemp growers.
Across the border, Canopy Growth Corp. (NYSE:CGC) has established acres
of Canadian hemp cultivation and gained financial backing that would support
huge growth. Aurora Cannabis, Inc. (OTC:ACBFF) has also received
substantial funding in the past few months, which will help its ongoing
expansion effort. Hemp cultivation will provide plentiful CBD to be used by
companies such as CV Sciences, Inc. (OTC:
CVSI) as an ingredient in a wide and growing range of health and wellness
products. All this growth is aided by support companies such as Terra Tech
Corp. (OTC: TRTC), which provides equipment for cannabis cultivators.
Hemp:
Caught Between Politics and Business
Industrial hemp
is a crop with a strange history in the United States. For centuries, it was
used to produce products such as ropes and sails, playing an integral part in
the economy. This ended in the twentieth century when hemp was caught up in a
broad ban on the cannabis family of plants, despite the fact that hemp itself is
not usable as a recreational drug. Now its tentative return depends upon the
outcome of a far broader agricultural bill. 
Because it
doesn’t share the psychoactive properties of marijuana, hemp has potential to be
regulated and grown separately. Early tests in restoring this industry have
produced significant profits for farmers. If the political will can be found to
change its status, it could create great opportunities for businesses and their
suppliers.
Hemp Cultivation Project in the United States
Several
companies, including
Marijuana
Company of America (OTC:MCOA),
are already growing hemp in the United States with their Scio, Oregon
Cultivation Project, in conjunction with their joint venture partner Global Hemp
Group Inc.
Under their
high-yielding CBD hemp cultivation projects, the two joint venture partners have
formed Covered Bridge Acres, LTD. The key to the project was the acquisition of
a 109-acre agricultural property in Scio, Oregon, with a history of hemp
cultivation over the past few years. In July 2018, 40,000 hemp clones were
planted on the property for Cannabidiol (CBD) propagation on approximately 33
acres of the property.
MCOA and GHG
are now in the process of evaluating different harvesting, drying, storage and
processing strategies in preparation of an early October harvest. The joint
venture partners are also in negotiations with guaranteed offtake agreement
offers and are considering strategies involved with selling the attained biomass
from harvest in bulk.
When Is a Drug Not a Drug?
Hemp is one of
a range of different cannabis plants. Unlike the versions smoked by recreational
users, it doesn’t contain significant quantities of tetrahydrocannabinol (THC),
the chemical that gets smokers high. It does contain the active ingredient
cannabidiol (CBD), which has been widely reported to have medicinal value —
reports that now have been
substantiated
by the U.S. Food and Drug Administration.
Importantly, hemp also contains fibers that can be used for a wide range of
purposes.
In the
twentieth century, cannabis plants were banned as the U.S. government and others
worldwide cracked down on drug use. Though hemp doesn’t get drug users high, the
governments apparently banned the cannabis plant because of the difficulty of
distinguishing between the plant varieties. The decision to include hemp in a
list of banned drugs was based on political expediency rather than science.
Fast forward to
the twenty-first century and
the rules
surrounding hemp have started to change,
allowing the creation of companies such as MCOA. Hemp has a huge number of
potential uses, including the manufacture of cloth and paper and the processing
of food. Under licenses designed to cater to research and the medical market,
farmers have begun growing industrial hemp with expectations of earning
up to 150 times
as much money per acre of land as they would growing alfalfa.
The Great Agricultural Debate
Farm bills are
an important part of how the U.S. government establishes policy around food and
agricultural production and how that policy is enshrined in law. Roughly every
five years, Congress creates a bill covering a wide range of agricultural
topics. With its huge financial implications and many different political
angles, passing the bill can be a messy business.
Following a
pilot research program for hemp growers created in the 2014 Farm Bill,
the current
Farm Bill includes the legalization of industrial hemp.
There’s a lot at stake for hemp growers as well as those hoping to enter and
establish a foothold in the industry. The U.S. Hemp Roundtable has gone so far
as to hire attorney Daniel Cameron, an experienced Washington legal counsel, to
lead its
advocacy on the bill.
The House and Senate have both passed versions of the 2018 Farm Bill that
support the legalization of the hemp industry without drug enforcement
oversight. On Sept. 5, the first bicameral conference committee on this Farm
Bill
began meeting in an attempt to resolve competing elements between the
two bills, with a deadline to present the president with an agreed-on final
version of the bill by the end of the month.
The good news for companies such as MCOA is that
the hemp element of the Farm Bill has cross-party support. Hemp’s
potential to revive the fortunes of American farmers makes it a potential
vote-winner for rural politicians nervously eyeing up the polls. The bad news is
that in a bill affecting everything from agricultural subsidies to environmental
conservation to food stamps, there’s plenty for politicians to disagree over.
Hemp Products
Sail cloth and
rigging were enough to make hemp profitable in the eighteenth century, but the
world has changed since then. So what sort of products can the world expect to
see from a resurgent hemp market?
Many products
will undoubtedly be targeted towards the health and wellness market, using CBD
as an active ingredient. A leading example of these types of products is MCOA’s
hempSMART line, including hempSMART Brain, which is developed to help with
alertness and concentration; hempSMART Pain Capsules and Pain Cream, formulated
to be an effective product combination for the temporary relief of minor pain
associated with physical activity; hempSMART Full Spectrum Drops; and hempSMART
Face, a nourishing facial moisturizer infused with Ayurvedic herbs and
botancials.
A Growing Industry
Many companies
already engaged in the cannabis market are exploring ways they may be able to
benefit from the growing popularity of hemp. Canopy Growth Corp.
(NYSE:CGC),
one of
Canada’s foremost cannabis companies, has a hemp division with expertise in this
area and
acres of hemp
production already under way.
The company also recently received a
$4 billion
investment from Constellation Brands,
a leading beverage company, to help it expand within the fast-growing cannabis
market. With such levels of investment, Canopy Growth will be in a strong
position to increase production as the market for hemp products grows.
The medical use
of CBD is a major area of interest for Aurora Cannabis, Inc. (OTCQX:ACBFF),
which is developing different strains of cannabis to benefit from their
different medical properties. Like Canopy Growth, Aurora has an eye to expansion
while the market is still young. Its
recent takeover
of MedReleaf
appears to be just one step in a far bigger plan. The company has just taken out
a $150 million loan with the Bank of Montreal, betting on the power of a
short-term financial boost to make it a market leader, more than capable of
repaying the debt when the time comes.
Another company
exploring the medical potential of CBD is CV Sciences, Inc. (OTCQB:CVSI).
CV Sciences has a strong focus on research, with a division devoted to
developing new drugs that use CBD as an active ingredient. Its consumer products
division works through health care providers, health food shops and online sales
to market CBD-based wellness products.
The increasing
number of growers is good news for supporting companies such as Terra Tech
Corp. (OTCQX:TRTC). Terra Tech produces growing systems — including moving
tables and hydroponics — for cannabis farmers. These products are designed to
increase the productivity of indoor cannabis cultivation, which is where a lot
of CBD and marijuana plants are grown. The company’s environmentally friendly
systems can reduce waste and thereby cut costs while also increasing
productivity.
The anticipated
changes in the U.S. laws governing hemp cultivation signal implications for a
large number of companies in the wider cannabis sector as well. If the Farm Bill
gets through Congress as expected this month, it could open up a sea change in
agricultural production and U.S. wellness industry products.
For more
information about Marijuana Company of America, please visit
Marijuana
Company of America (OTC:MCOA).
About
CannabisNewsWire
CannabisNewsWire (CNW) is an information service that provides (1) access to our
news aggregation and syndication servers, (2)
CannabisNewsBreaks that summarize corporate news and information, (3)
enhanced press release services, (4) social media distribution and optimization
services, and (5) a full array of corporate communication solutions. As a
multifaceted financial news and content distribution company with an extensive
team of contributing journalists and writers, CNW is uniquely positioned to best
serve private and public companies that desire to reach a wide audience of
investors, consumers, journalists and the general public. CNW has an
ever-growing distribution network of more than 5,000 key syndication outlets
across the country. By cutting through the overload of information in today’s
market, CNW brings its clients unparalleled visibility, recognition and brand
awareness. CNW is where news, content and information converge.
Receive Text Alerts from CannabisNewsWire:
Text "Cannabis" to 21000
For more
information please visit
https://www.CannabisNewsWire.com
and or
https://CannabisNewsWire.News
Please see full
terms of use and disclaimers on the CannabisNewsWire website applicable to all
content provided by CNW, wherever published or re-published:
http://CNW.fm/Disclaimer
DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article
and content set forth above. References to any issuer other than the profiled
issuer are intended solely to identify industry participants and do not
constitute an endorsement of any issuer and do not constitute a comparison to
the profiled issuer. FN Media Group (FNM) is a third-party publisher and news
dissemination service provider, which disseminates electronic information
through multiple online media channels. FNM is NOT affiliated with CNW or any
company mentioned herein. The commentary, views and opinions expressed in this
release by CNW are solely those of CNW and are not shared by and do not reflect
in any manner the views or opinions of FNM. Readers of this Article and content
agree that they cannot and will not seek to hold liable CNW and FNM for any
investment decisions by their readers or subscribers. CNW and FNM and their
respective affiliated companies are a news dissemination and financial marketing
solutions provider and are NOT registered broker-dealers/analysts/investment
advisers, hold no investment licenses and may NOT sell, offer to sell or offer
to buy any security.
The Article and content related to the profiled company represent the personal
and subjective views of the Author, and are subject to change at any time
without notice. The information provided in the Article and the content has been
obtained from sources which the Author believes to be reliable. However, the
Author has not independently verified or otherwise investigated all such
information. None of the Author, CNW, FNM, or any of their respective
affiliates, guarantee the accuracy or completeness of any such information. This
Article and content are not, and should not be regarded as investment advice or
as a recommendation regarding any particular security or course of action;
readers are strongly urged to speak with their own investment advisor and review
all of the profiled issuer's filings made with the Securities and Exchange
Commission before making any investment decisions and should understand the
risks associated with an investment in the profiled issuer's securities,
including, but not limited to, the complete loss of your investment.
CNW & FNM HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release
contains "forward-looking statements" within the meaning of Section 27A of the
Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act
of 1934, as amended and such forward-looking statements are made pursuant to the
safe harbor provisions of the Private Securities Litigation Reform Act of 1995.
"Forward-looking statements" describe future expectations, plans, results, or
strategies and are generally preceded by words such as "may", "future", "plan"
or "planned", "will" or "should", "expected," "anticipates", "draft",
"eventually" or "projected". You are cautioned that such statements are subject
to a multitude of risks and uncertainties that could cause future circumstances,
events, or results to differ materially from those projected in the
forward-looking statements, including the risks that actual results may differ
materially from those projected in the forward-looking statements as a result of
various factors, and other risks identified in a company's annual report on Form
10-K or 10-KSB and other filings made by such company with the Securities and
Exchange Commission. You should consider these factors in evaluating the
forward-looking statements included herein, and not place undue reliance on such
statements. The forward-looking statements in this release are made as of the
date hereof and CNW and FNM undertake no obligation to update such statements.
CannabisNewsWire (CNW) & NetworkNewsWire (NNW) are proud to be affiliated
partners of the Investor Brand Network (IBN)
About IBN
Over the past 10+ years we have consistently introduced new network brands,
each specifically designed to fulfil the unique needs of our growing client base
and services. Today, we continue to expand our branded network of highly
influential properties, leveraging the knowledge and energy of specialized teams
of experts to serve our increasingly diversified list of clients.
Please feel free to visit the Investor Brand Network (IBN)
http://www.InvestorBrandNetwork.com
Corporate Communications Contact:
CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net
Media Contact:
FN Media Group,
LLC
NNW@FinancialNewsMedia.com
+1-(954)345-0611
Source:
CannabisNewsWire
MARIJUANA COMPANY OF AMERICA
PROVIDES UPDATE ON CBD HEMP JOINT VENTURE FARMING PROJECT IN NEW BRUNSWICK
CANADA
ESCONDIDO, CA -- August 30, 2018 -- MARIJUANA COMPANY OF
AMERICA INC. (OTC: MCOA)
("MCOA" or the "Company"), an innovative hemp and cannabis corporation, and
its joint venture partner Global Hemp Group Inc. (CSE: GHG) (OTC:GBHPF)
(FRANKFURT: GHG) (the “Partners”) are pleased to provide an update on their CBD
hemp farming joint venture in New Brunswick, Canada (the “Project”).
Dryer Installation
Drying of the biomass is an important first step in the extraction of the
cannabinoids from the hemp plant. The partners are pleased to announce that the
Project’s industrial scale dryer from Cann Systems was delivered last week and
has now been installed.
The dryer holds multiple bins of material, for a total processing capacity of
just over one tonne of fresh hemp biomass per load. Initial testing is in
progress and will be completed by the end of this week. Once the biomass has
been dried from thi s
year’s harvest, it will be stored until the implementation of the Cannabis Act
on Oct. 17, 2018, at which time the biomass can be legally sold for extraction.
Health Canada has recently issued a new
Class Exemption to the Industrial Hemp Regulations that allows hemp
cultivation license holders to legally harvest, dry and store flowers, leaves
and branches prior to the passage of the Cannabis Act. Management is currently
in discussions with potential offtakers for selling the dried biomass in bulk,
as well as exploring potential strategies for toll extraction and the marketing
and distribution of processed and refined oils.
Innovation in the Hemp Industry
It is now nearing harvest time at the New Brunswick Hemp Project. To maximize
profit, it is important to harvest as much of the higher CBD content flowers and
leaves as possible, without undue amounts of the low to no CBD straw (the
stalk). This year’s drought has complicated matters as the hemp plants have
tended to be shorter than usual, and the weeds are taller as they were able to
get a head start before the hemp began growing, although the hemp is still
displaying very healthy and weighty inflorescence. These issues that are
perceived as problems at they occur, may benefit the hemp plants which tend to
produce more biomass as a result of stress from competition with weeds and the
effects of the drought.
In order to succeed in the hemp industry, a certain amount of ingenuity and
innovation is required more often than not. Our farming group is a good example
of this ingenuity. Sometimes repurposing existing equipment on hand will work to
achieve the required result. To combat the higher than normal weed height and to
maximize the value of the harvest by taking just the most valuable parts of the
hemp plant, a small harvesting trial was conducted by one of our farmers using
an OXBO bean harvester. The bean harvester is able to strip the plant of all
leaves and inflorescence, while picking up very little straw, which is ideal for
this year’s crop. Based on the positive results of this trial, the bean
harvester will be used to complete the harvest of the entire 125 acres of hemp
cultivated under the joint venture project with MCOA this year.
In non-drought years, other harvesting tools will be required and the innovative
farmers of our group have already begun strategizing on potential solutions that
will be applicable next year when the Partners move forward with an aggressive
expansion strategy to significantly increase CBD acreage as well as fully
exploit the whole hemp plant and process the straw for industrial applications.
New Research Collaboration
The drought in northeast New Brunswick has not affected all fields uniformly.
One of our fields is reported by DAAF field agrologists as “one of the finest of
the province”. Aside from the obvious economic benefit in terms of increased
yields, this field offers the opportunity to contrast high and low performing
plants of a given variety in the same location, shedding some light on the role
of plant nutrition in explaining the performance of hemp plants. Dr. Ron Smith
from University of New Brunswick will spearhead a research project focused on
the issue. The Partners and the National Research Council have committed to
provide financial support for the study.
About Marijuana Company of America, Inc.
MCOA is a corporation which participates in: (1) product research and
development of legal hemp-based consumer products under the brand name
“hempSMART™”, that targets general health and well-being; (2) an affiliate
marketing program to promote and sell its legal hemp-based consumer products
containing CBD; (3) leasing of real property to separate business entities
engaged in the growth and sale of cannabis in those states and jurisdictions
where cannabis has been legalized and properly regulated for medicinal and
recreations use; and, (4) the expansion of its business into ancillary areas of
the legalized cannabis and hemp industry, as the legalized markets and
opportunities in this segment mature and develop.
About Global Hemp Group Inc.
Global Hemp Group Inc. (CSE: GHG) (OTC: GBHPF) (FRANKFURT: GHG), is
headquartered in Vancouver, British Columbia, Canada, with base operations in
Montreal and Los Angeles. The Company is focused on a multi-phased strategy to
build a strong presence in the industrial hemp industry in both Canada and the
United States. The first phase of this strategy is to develop hemp cultivation
with the objective of extracting cannabinoids (CBD, CBG, CBN & CBC) and creating
a near term revenue stream that will allow the Company to expand and develop
successive phases of the strategy. The second phase of the plan will focus on
the development of value-added industrial hemp products utilizing the processing
of the whole hemp plant, as envisioned in the Company’s Hemp Agro-Industrial
Zone (HAIZ) strategy.
Forward Looking Statements
This news release contains "forward-looking statements" which are not purely
historical and may include any statements regarding beliefs, plans, expectations
or intentions regarding the future. Such forward-looking statements include,
among other things, the development, costs and results of new business
opportunities and words such as "anticipate", "seek", intend", "believe",
"estimate", "expect", "project", "plan", or similar phrases may be deemed
"forward-looking statements" within the meaning of the Private Securities
Litigation Reform Act of 1995. Actual results could differ from those projected
in any forward-looking statements due to numerous factors. Such factors include,
among others, the inherent uncertainties associated with new projects, the
future U.S. and global economies, the impact of competition, and the Company's
reliance on existing regulations regarding the use and development of
cannabis-based products. These forward-looking statements are made as of the
date of this news release, and we assume no obligation to update the
forward-looking statements, or to update the reasons why actual results could
differ from those projected in the forward-looking statements. Although we
believe that any beliefs, plans, expectations and intentions contained in this
press release are reasonable, there can be no assurance that any such beliefs,
plans, expectations or intentions will prove to be accurate. Investors should
consult all of the information set forth herein and should also refer to the
risk factors disclosure outlined in our annual report on Form 10-12G, our
quarterly reports on Form 10-Q and other periodic reports filed from
time-to-time with the Securities and Exchange Commission. For more information,
please visit www.sec.gov.
For more information, please visit the Company’s websites at:
MarijuanaCompanyofAmerica.com
hempSMART.com
NetworkNewsWires/MCOA
Source: Marijuana Company of America, Inc.
MARIJUANA COMPANY OF AMERICA
PROVIDES UPDATE ON ITS INVESTMENT IN MONEYTRAC TECHNOLOGY
ESCONDIDO, CA -- August 29, 2018 -- MARIJUANA COMPANY OF
AMERICA INC. (OTC: MCOA)
("MCOA" or the "Company"), an innovative hemp and cannabis corporation, is
pleased to announce that it has received 150,000,000 shares of common stock of
Global Payout Inc. (OTC: “GOHE”) as part its reverse merger with
MoneyTrac Technology. Based on the market price of GOHE’s stock on the date of
the share issuance, MCOA has a contingent unrealized gain of approximately 700%
on its $250,000 investment, subject to future price fluctuations in the market
for GOHE’s stock.
On March 13, 2017, MCOA entered into a stock purchase agreement to acquire
15,000,000 common shares of MoneyTrac Technology, Inc., for a total purchase
price of $250,000.
As part of MoneyTrac’s merger with GOHE, GOHE issued shares from treasury to
MCOA on August 24, 2018. On the date of the share issuance, the closing price of
GOHE’s stock was $.0116 a share, valuing the 150M shares position at
approximately $1,740,000.

Regarding the share issuance, Don Steinberg, President and CEO stated, “we are
pleased to announce that we have received a substantial amount of stock in GOHE.
Since we are receiving stock in a publicly traded company, we have the
opportunity to realize a gain from our investment in MoneyTrac to help provide
the Company with capital to help accomplish our aggressive growth goals and
business plan in 2018.”
About Marijuana Company of America, Inc.
MCOA is a corporation which participates in: (1) product research and
development of legal hemp-based consumer products under the brand name
“hempSMART™”, that targets general health and well-being; (2) an affiliate
marketing program to promote and sell its legal hemp-based consumer products
containing CBD; (3) leasing of real property to separate business entities
engaged in the growth and sale of cannabis in those states and jurisdictions
where cannabis has been legalized and properly regulated for medicinal and
recreations use; and, (4) the expansion of its business into ancillary areas of
the legalized cannabis and hemp industry, as the legalized markets and
opportunities in this segment mature and develop.
About Global Payout, Inc. (OTC Pink:GOHE)
Since the Company's inception in 2009, Global Payout, Inc. has been a leading
provider of comprehensive and customized prepaid payment solutions for domestic
and international organizations distributing money worldwide. In 2014, Global
introduced its first online payment platform called the Consolidated Payment
Gateway (CPG), which allowed its enterprise clients to transfer money to
international bank accounts, mobile accounts, and prepaid card accounts. The
development of the CPG became the foundation for the introduction of its new,
state of the art FINTECH payment system in 2017, for both online and mobile
applications to allow account holders to maximize an expanded suite of financial
services and minimize operational costs. Global will continue to offer their
FINTECH payment system to many vertical markets for support of foreign currency
exchange and digital currency, including ongoing support of the banking industry
and international governments.
About MoneyTrac Technology
MoneyTrac Technology, Inc. (MTRAC) is a “New Age Technology Holding Company”
offering a full-service solution for alternative banking and electronic
financial marketplace with technology offerings including Payment Platform,
Blockchain, Crypto-Commodity Exchange, Compliance, POS, E-Wallet, Mobile
Application and Digital Payment Solutions for businesses and companies in
various “high-costs of banking” industries. MTRAC offers additional suites of
services ranging from business development, sales and marketing, to digital and
print advertisement. We are One Network disrupting the status quo. It is MTRAC’S
creative vision to create a “The New Age of Currency™” by bringing innovative
technology solutions to various industries and providing the “Key to Cashless™.”
Forward Looking Statements
This news release contains "forward-looking statements" which are not purely
historical and may include any statements regarding beliefs, plans, expectations
or intentions regarding the future. Such forward-looking statements include,
among other things, the development, costs and results of new business
opportunities and words such as "anticipate", "seek", intend", "believe",
"estimate", "expect", "project", "plan", or similar phrases may be deemed
"forward-looking statements" within the meaning of the Private Securities
Litigation Reform Act of 1995. Actual results could differ from those projected
in any forward-looking statements due to numerous factors. Such factors include,
among others, the inherent uncertainties associated with new projects, the
future U.S. and global economies, the impact of competition, and the Company's
reliance on existing regulations regarding the use and development of
cannabis-based products. These forward-looking statements are made as of the
date of this news release, and we assume no obligation to update the
forward-looking statements, or to update the reasons why actual results could
differ from those projected in the forward-looking statements. Although we
believe that any beliefs, plans, expectations and intentions contained in this
press release are reasonable, there can be no assurance that any such beliefs,
plans, expectations or intentions will prove to be accurate. Investors should
consult all of the information set forth herein and should also refer to the
risk factors disclosure outlined in our annual report on Form 10-12G, our
quarterly reports on Form 10-Q and other periodic reports filed from
time-to-time with the Securities and Exchange Commission. For more information,
please visit www.sec.gov.
For more information, please visit the Company’s websites at:
MarijuanaCompanyofAmerica.com
hempSMART.com
NetworkNewsWires/MCOA
Specific Therapeutic Benefits of Cannabidiol (CBD) Validated by FDA
New York, NY –
August 8, 2018 –
CannabisNewsWire.com News Coverage:
The hemp industry is growing in North America and appears to be set for further
expansion thanks to legislation making its way through the U.S. Senate.
-
Hemp is a cultivar
of the cannabis sativa plant that lacks the active drug ingredient that
makes marijuana users high.
-
It can be used to
produce medicinal CBD oil as well as fibers for rope, paper and canvas
-
Even in difficult
growing conditions, hemp can provide higher profits than many other crops.
-
It has a lower
environmental impact thanks to low water consumption and little need for
chemical fertilizers or pesticides.
Marijuana Company of America, Inc. (OTC:MCOA) has hemp already
growing at cultivation sites in Canada and the United States, experimenting with
improved strains and cultivation techniques. As a provider of hydroponic
equipment, Scotts Miracle-Gro Company (The) (NYSE:SMG) is benefiting from
the growing cannabis industry and will likely see increased sales thanks to a
recent acquisition. Another provider of hydroponics, GrowGeneration
Corporation (OTC:GRWG), has already seen a dramatic increase in sales thanks
to acquisitions and the rise of cannabis. Micron Waste Technologies, Inc.
(OTC:MICWF) (CSE:MWM) is launching specialist waste treatment equipment for
cannabis growers. And as federal hemp legislation comes closer to passage,
Future Farm Technologies (OTC:FFRMF) (CSE:FFT) is producing millions of hemp
seeds ready to be planted by farmers in Maine.
To view an infographic of this editorial,
click here.
Bringing Hemp Back
The past decade has seen a rush to embrace legal cannabis
in North America. In the United States, 31 of the 50 states now allow its use
for medicinal purposes while another 15 allow products derived from cannabis but
with restrictions o n
their active chemicals. Nine states also allow the sale and use of recreational
cannabis.
These changes have largely overlooked an important class of cannabis: hemp. This
variety of the cannabis sativa plant does not contain tetrahydrocannabinol
(THC), the psychoactive ingredient that is the basis of marijuana’s recreational
appeal. Historically used in making rope and fabric, hemp became illegal
alongside other forms of cannabis because there was no way to distinguish
between them. But with new ways to provide that differentiation, industrial hemp
appears to be on the cusp of returning to widespread agricultural use in the
United States.
The Hemp Revival
Changes in legislation have already allowed a number of
companies, including
Marijuana Company of America, Inc. (OTC:MCOA), to start growing hemp
in the United States and Canada. But as with so much else about cannabis
production, this has been somewhat hampered by restrictions at the federal
level.
Now a change appears to be forthcoming.
In 2014, the Farm Bill allowed farmers to start growing hemp for research
purposes. Hemp farming quickly took off, reaching 25,713 acres of harvested land
in 2017. And current efforts are afoot to make the crop fully legal.
This isn’t just a publicity-grabbing move from the liberal left. A bill put
before Congress by Republican Sen. Mitch McConnell of Kentucky aims to make hemp
cultivation legal. It has cross-party support and looks likely to pass despite
the partisan divides in Washington. If it does, the bill will allow companies
such as MCOA to expand their efforts and may encourage more farmers to grow
hemp.
The financial potential of a hemp crop is staggering. The plants can currently
be used to produce cannabidiol (CBD) oil, which is used in medicines and
wellness products such as those sold by MCOA. Some farmers are expecting
revenues of $90,000 per acre for the oil, compared with only $600 per acre
for alfalfa, which is currently one of the most popular crops in the United
States.
There’s even more profit to be made from a properly developed hemp industry.
Given full legalization, a revival of such ancillary industries could allow
farmers to profit from both CBD oil and what is currently a waste product once
the plant is processed, reviving the hemp fiber industry after nearly a century.
A Better Crop for the Environment
One of the great advantages of hemp is that it’s easier to grow in dry climates
than many other crops. Though it needs more water than other crops during the
first few weeks of growth, hemp subsequently needs less water and is less
vulnerable to drought. This makes it an ideal crop for farmers in arid
environments, such as parts of the western United States, as well as those
currently facing the impact of climate change.
Reduced water consumption is one of several factors that make hemp an
environmentally friendly crop. Growing hemp doesn’t require pesticides and
herbicides, meaning that the soil can be left clean and given a chance to
recover between other crops. Hemp can also be used instead of trees to produce
paper fibers, thus saving trees and reducing the geographical footprint of paper
production.
Hemp is a fast-growing plant, capable of growing up to 20 feet in 100 days,
allowing farmers to potentially grow a substantial crop in a relatively small
area, even in soil conditions where other plants might struggle to survive. With
legalization expected with the passing of the Farm Bill, hemp cultivation may
grow beyond the small crop levels currently established by companies such as
MCOA.
An increasing number of farmers are already planting hemp. Once the red tape
is eliminated, more will surely jump on board this bandwagon.
Getting Ahead of a Growing Industry
This change is good news for MCOA and its existing hemp
cultivation projects. Legal change will give the company credibility as an early
adopter in a suddenly expanding field, with the advantages in technique that
experience brings.
One of the company’s projects is the continued development of Hemp
Agro-Industrial Zone (HAIZ) in New Brunswick, Canada, with its partner Global
Hemp Group (CSE:GHG). There, MCOA and GHG have been working with the government
to explore different approaches to hemp cultivation and encourage the industry
in the region.
Supported by a government grant, MCOA and GHG have been conducting
experiments that study and evaluate soil conditions and pest problems that could
affect hemp crops. Drones allow researchers to accurately assess the success of
crops and gain a better understanding of what makes hemp grow best.
More recently, the company has also established a
hemp cultivation site in the state of Oregon in another joint venture
project with GHG. This 109-acre site features both indoor and outdoor
cultivation that allows the company to maintain a steady supply of plants
throughout the year.
At the Oregon facility, MCOA and GHG are cultivating hemp varieties with
particularly strong yields of CBD. This active ingredient in hemp is being used
in a growing variety of medical and wellness products, with applications
including increased alertness, the control of epilepsy and pain management. By
collecting and analyzing data on hemp strains to augment CBD development,
MCOA hopes to establish better profits and wider availability for this important
medicine.
Businesses Benefit from Hemp
The ascendance of hemp cultivation and the wider cannabis sector is bringing
benefits for companies in supporting services. Scotts Miracle-Gro Company
(The) (NYSE:SMG) recently
completed the acquisition of Sunlight Supply, Inc., the leading distributor
of hydroponics products in the United States. This $450 million deal is the
largest transaction Scotts has ever made and will double its sales to cannabis
growers, who make extensive use of hydroponic equipment. The lawns and gardens
specialist might not be growing cannabis, but as legalization spreads and the
sector grows, the company certainly stands to profit from the plant.
Another provider of growing equipment, GrowGeneration Corporation (OTCQX:GRWG),
is also set to benefit from an expanding sector. By selling hydroponic systems,
nutrients and materials for hydroponic cultivation, the company has seen a
steady increase in its profits. Its
sales increased 80 percent in 2017, and it
has acquired several smaller companies to ensure its growth. The company expects
U.S. hydroponic sales to exceed $4.5 billion by 2020, thanks to exponential
growth driven by the cannabis sector.
Micron Waste Technologies, Inc. (OTC:MICWF) (CSE:MWM) also supports
cannabis cultivators but in a different way. The company provides onsite waste
management systems that turn organic waste into clean water. Micron Waste has
targeted marijuana cultivators as one of the markets for its products. To
celebrate this growing market, the company recently
ran a contest to name its specialist cannabis waste digester.
Another specialist in indoor growing equipment, Future Farm Technologies
(OTCQX:FFRMF) (CSE:FFT) specializes in LED lighting and vertical farming
solutions. Not content with providing supplies to the cannabis sector, the
company has entered the market itself with a hemp farm in Maine. The farm is
soon expected to provide
over 15 million hemp seeds to farmers in the region, which will allow the
growers to quickly increase hemp cultivation if the current Farm Bill passes
into law.
After being banned for decades, industrial hemp is seeing a rapid rise in North
America. It offers opportunities for farmers and suppliers of cultivation
equipment. And perhaps most importantly, it offers an environmentally friendly
crop for difficult growing conditions.
For more information about Marijuana Company of America, please visit
Marijuana Company of America Inc. (OTC:MCOA).
About CannabisNewsWire
CannabisNewsWire (CNW) is an information service that provides (1) access to our
news aggregation and syndication servers, (2)
CannabisNewsBreaks that summarize corporate
news and information, (3) enhanced press release services, (4) social media
distribution and optimization services, and (5) a full array of corporate
communication solutions. As a multifaceted financial news and content
distribution company with an extensive team of contributing journalists and
writers, CNW is uniquely positioned to best serve private and public companies
that desire to reach a wide audience of investors, consumers, journalists and
the general public. CNW has an ever-growing distribution network of more than
5,000 key syndication outlets across the country. By cutting through the
overload of information in today’s market, CNW brings its clients unparalleled
visibility, recognition and brand awareness. CNW is where news, content and
information converge.
Receive Text Alerts from CannabisNewsWire:
Text "Cannabis" to 21000
For more
information please visit
https://www.CannabisNewsWire.com
and or
https://CannabisNewsWire.News
Please see full terms of use and disclaimers on the CannabisNewsWire website
applicable to all content provided by CNW, wherever published or re-published:
http://CNW.fm/Disclaimer
DISCLAIMER: CannabisNewsWire (CNW) is the source of the
Article and content set forth above. References to any issuer other than the
profiled issuer are intended solely to identify industry participants and do not
constitute an endorsement of any issuer and do not constitute a comparison to
the profiled issuer. FN Media Group (FNM) is a third-party publisher and news
dissemination service provider, which disseminates electronic information
through multiple online media channels. FNM is NOT affiliated with CNW or any
company mentioned herein. The commentary, views and opinions expressed in this
release by CNW are solely those of CNW and are not shared by and do not reflect
in any manner the views or opinions of FNM. Readers of this Article and content
agree that they cannot and will not seek to hold liable CNW and FNM for any
investment decisions by their readers or subscribers. CNW and FNM and their
respective affiliated companies are a news dissemination and financial marketing
solutions provider and are NOT registered broker-dealers/analysts/investment
advisers, hold no investment licenses and may NOT sell, offer to sell or offer
to buy any security.
The Article and content related to the profiled company represent the personal
and subjective views of the Author, and are subject to change at any time
without notice. The information provided in the Article and the content has been
obtained from sources which the Author believes to be reliable. However, the
Author has not independently verified or otherwise investigated all such
information. None of the Author, CNW, FNM, or any of their respective
affiliates, guarantee the accuracy or completeness of any such information. This
Article and content are not, and should not be regarded as investment advice or
as a recommendation regarding any particular security or course of action;
readers are strongly urged to speak with their own investment advisor and review
all of the profiled issuer's filings made with the Securities and Exchange
Commission before making any investment decisions and should understand the
risks associated with an investment in the profiled issuer's securities,
including, but not limited to, the complete loss of your investment.
CNW & FNM HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains "forward-looking statements" within the meaning of Section
27A of the Securities Act of 1933, as amended, and Section 21E the Securities
Exchange Act of 1934, as amended and such forward-looking statements are made
pursuant to the safe harbor provisions of the Private Securities Litigation
Reform Act of 1995. "Forward-looking statements" describe future expectations,
plans, results, or strategies and are generally preceded by words such as "may",
"future", "plan" or "planned", "will" or "should", "expected," "anticipates",
"draft", "eventually" or "projected". You are cautioned that such statements are
subject to a multitude of risks and uncertainties that could cause future
circumstances, events, or results to differ materially from those projected in
the forward-looking statements, including the risks that actual results may
differ materially from those projected in the forward-looking statements as a
result of various factors, and other risks identified in a company's annual
report on Form 10-K or 10-KSB and other filings made by such company with the
Securities and Exchange Commission. You should consider these factors in
evaluating the forward-looking statements included herein, and not place undue
reliance on such statements. The forward-looking statements in this release are
made as of the date hereof and CNW and FNM undertake no obligation to update
such statements.
CannabisNewsWire (CNW) & NetworkNewsWire (NNW) are proud to be affiliated
partners of the Investor Brand Network (IBN)
About IBN
Over the past 10+ years we have consistently introduced new network brands,
each specifically designed to fulfil the unique needs of our growing client base
and services. Today, we continue to expand our branded network of highly
influential properties, leveraging the knowledge and energy of specialized teams
of experts to serve our increasingly diversified list of clients.
Please feel free to visit the Investor Brand Network (IBN)
http://www.InvestorBrandNetwork.com
Corporate
Communications Contact:
CannabisNewsWire (CNW)
Denver,
Colorado
www.CannabisNewsWire.com
303.498.7722
Office
Editor@CannabisNewsWire.net
Media Contact:
FN Media Group,
LLC
NNW@FinancialNewsMedia.com
+1-(954)345-0611
News Source:
CannabisNewsWire
MARIJUANA COMPANY OF AMERICA
PROVIDES UPDATE ON ITS HEMP CBD JOINT VENTURE PROJECT WITH GLOBAL HEMP GROUP IN
CANADA
ESCONDIDO, CA -- August 21, 2018 -- MARIJUANA COMPANY OF
AMERICA INC. (OTC: MCOA)
("MCOA" or the "Company"), an innovative hemp and cannabis corporation, and
its joint venture partner Global Hemp Group Inc. (CSE: GHG) (OTC: GBHPF)
(Frankfurt: GHG) (the “Partners”) are pleased to provide an update on their CBD
hemp farming joint venture in New Brunswick, Canada (the “Project”).
The goal of the hemp project in northeast New Brunswick is, in part, to produce
hemp biomass that can be used for the extraction of cannabinoids. In
anticipation of Canada’s implementation of the Cannabis Act on October 17, 2018,
which will allow for the processing of the entire hemp plant, the Partners began
preparing its Bathurst facility for the installation of
drying equipment capable of drying 125 acres of flowers and leaves from the 2018
cultivation.
The flowers and leaves of the hemp plant are rich in cannabinoids, notably
containing non-psychoactive compounds of Cannabidiol (CBD). CBD, which has
gained increasing popularity as of late, has been found to be effective
component in a complete personal wellness regimen that has produced an increased
demand from consumers for products containing CBD. The Hemp Business Journal
estimated that the CBD market will
grow to a $2.1 billion market in consumer sales by 2020.
Health Canada issues Class Exemption to the Industrial Hemp Regulations
Health Canada, the governing body in charge of industrial hemp licensing and its
regulations in Canada, has recently issued a new Class Exemption in Relation to
the Industrial Hemp Regulations (flowering heads, leaves and branches). This
will allow the Partners to legally harvest, dry and store flowering heads,
leaves and branches of industrial hemp from its 2018 cultivation, prior to the
implementation of the Cannabis Act on October 17, 2018, when extraction of CBD
from the flowers and leaves from industrial hemp will be legal in Canada. This
will enable the industry to take advantage of an entirely new product market
utilizing hemp derived cannabinoids.
New Brunswick Facilities
A 4,000 sq. ft. facility was secured in Bathurst, NB for the project in June.
The Joint Venture established its offices and soon will complete the
installation of processing equipment in the facility. A biomass dryer to process
the flowers and leaves from participating farms will be installed before the end
of August. The dried flowers and leaves will be stored until mid-October when
the Joint Venture is allowed to sell its product to CBD extractors. Once proper
licenses have been acquired for importing and manufacturing finished CBD
products, the Bathurst facility may also serve as a distribution center for the
hempSMARTTM products that are currently manufactured and distributed in the
United States by GHG’s partner: MCOA.
Advanced Crop Monitoring – Successful First Drone Flight
In a large hemp field with tall dense crops, it is impossible to identify
stressed areas from ground level. The use of specialized drones can provide
targeted field diagnostics. When a stressed area is identified, the observer can
move directly to that location to assess the conditions of the observed stress.
Three drone flyovers have been contracted for the project. Each flyover will
provide a colored image indicating the state of the vegetation, with data
collected from random points in the different colored zones to assess the actual
conditions on the ground. Data collected includes the measurement of soil
moisture, pH, plant height and insect-disease-pressure. Once properly
calibrated, these images will become an effective crop management tool for
future crops in the region.
Severe Drought
Northeast New Brunswick has been experiencing a severe drought this year. The
incidence of the drought has varied in intensity, but is widespread across the
region. One of the participating farmers reported that this year’s drought was
the worst he experienced in his lifetime. While most crops of the region were
hit very hard, as revealed by farm-gate prices of hay, hemp has faired
relatively well, as it is far less water consumption demands. Preliminary
observations collected from the first drone flyover over three of the farms
indicate the extent of the stress observed.
It is noted that of the three varieties cultivated this year, the Joey and
Canada varieties fared better than the Finola. Preliminary testing has indicated
that the output of flowers and leaves does not appear to be affected by the
drought. The attached photo shows the flowers that have been produced.
About Marijuana Company of America, Inc.
MCOA is a corporation which participates in: (1) product research and
development of legal hemp-based consumer products under the brand name
“hempSMART™”, that targets general health and well-being; (2) an affiliate
marketing program to promote and sell its legal hemp-based consumer products
containing CBD; (3) leasing of real property to separate business entities
engaged in the growth and sale of cannabis in those states and jurisdictions
where cannabis has been legalized and properly regulated for medicinal and
recreations use; and, (4) the expansion of its business into ancillary areas of
the legalized cannabis and hemp industry, as the legalized markets and
opportunities in this segment mature and develop.
About Global Hemp Group Inc.
Global Hemp Group Inc. (CSE: GHG) (OTC: GBHPF) (FRANKFURT: GHG), is
headquartered in Vancouver, British Columbia, Canada, with base operations in
Montreal and Los Angeles. The Company is focused on a multi-phased strategy to
build a strong presence in the industrial hemp industry in both Canada and the
United States. The first phase of this strategy is to develop hemp cultivation
with the objective of extracting cannabinoids (CBD, CBG, CBN & CBC) and creating
a near term revenue stream that will allow the Company to expand and develop
successive phases of the strategy. The second phase of the plan will focus on
the development of value-added industrial hemp products utilizing the processing
of the whole hemp plant, as envisioned in the Company’s Hemp Agro-Industrial
Zone (HAIZ) strategy.
Forward Looking Statements
This news release contains "forward-looking statements" which are not purely
historical and may include any statements regarding beliefs, plans, expectations
or intentions regarding the future. Such forward-looking statements include,
among other things, the development, costs and results of new business
opportunities and words such as "anticipate", "seek", intend", "believe",
"estimate", "expect", "project", "plan", or similar phrases may be deemed
"forward-looking statements" within the meaning of the Private Securities
Litigation Reform Act of 1995. Actual results could differ from those projected
in any forward-looking statements due to numerous factors. Such factors include,
among others, the inherent uncertainties associated with new projects, the
future U.S. and global economies, the impact of competition, and the Company's
reliance on existing regulations regarding the use and development of
cannabis-based products. These forward-looking statements are made as of the
date of this news release, and we assume no obligation to update the
forward-looking statements, or to update the reasons why actual results could
differ from those projected in the forward-looking statements. Although we
believe that any beliefs, plans, expectations and intentions contained in this
press release are reasonable, there can be no assurance that any such beliefs,
plans, expectations or intentions will prove to be accurate. Investors should
consult all of the information set forth herein and should also refer to the
risk factors disclosure outlined in our annual report on Form 10-12G, our
quarterly reports on Form 10-Q and other periodic reports filed from
time-to-time with the Securities and Exchange Commission. For more information,
please visit www.sec.gov.
For more information, please visit the Company’s websites at:
MarijuanaCompanyofAmerica.com
hempSMART.com
NetworkNewsWires/MCOA
Source: Marijuana Company of America, Inc.
Specific Therapeutic Benefits of Cannabidiol (CBD) Validated by FDA
New York, NY –
August 8, 2018 –
CannabisNewsWire.com News Coverage:
In a
landmark announcement,
the U.S. Food and Drug Administration (FDA) recently approved a drug derived
from pure cannabidiol (CBD), Epidiolex, to treat seizures associated with
certain forms of severe epilepsy, setting the stage for huge changes in the
world of cannabidiol (CBD).
-
·
FDA approval of a cannabis-based drug represents seismic political, legal
and economic shifts
-
·
Approval likely will lead to more clinical research and further validation
of CBD therapeutic efficacy
-
·
CBD market projected to explode to more than $2 billion in two years with 39
percent CAGR
What’s most transformative about this drug approval is that this
is the first time the FDA — the governmental arbiter of safe and
effective medicine in the United States — has approved any substance derived
from the cannabis sativa plant and validated certain therapeutic benefits of
cannabidiol. The FDA is, to some extent, endorsing what has been anecdotally
accepted by the masses for millennia.

CBD, a non-psychoactive cannabinoid that can be extracted from
the industrial hemp plant, is understandably generating worldwide interest from
both the scientific and investment communities. A large part of CBD’s mass
appeal is that it’s believed to aid with a broad range of wellness concerns. CBD
is known to interact with the human endocannabinoid system, which is found
throughout the body’s nervous system, organs, connective tissues, glands and
immune system. Research indicates
CBD may have the potential to treat a wide range of conditions such as
anxiety,
high blood pressure,
skin issues,
and chronic
pain. It’s being researched to
treat Alzheimer’s, and one study even suggests CBD might be a useful addition
when given with conventional antipsychotic medications in the treatment
of schizophrenia.
Continued rigorous clinical research is being conducted to further confirm all
the potential therapeutic benefits that may be found in this cannabinoid
extract. In the meantime, the mass appeal of CBD remains unabated, and the
market for CBD products continues to grow at an astounding rate. Committed to
the legal hemp-derived CBD market
,
Marijuana Company of America (OTC: MCOA) provides consumers with pure, hemp
plant-based CBD nutritional products through its global hempSMART™ brand and has
initiated broad-ranging, innovative cultivation programs for legal, high-quality
hemp. Others vying for position in the burgeoning CBD space include
Isodiol International, Inc. (CSE:ISOL)
(OTC:ISOLD) (FSE: LB6A.F), CV Sciences,
Inc. (OTC:CVSI),
PotNetwork Holdings, Inc. (OTC:POTN) and
Medical Marijuana, Inc. (OTC:MJNA).
The
Boom Has Just Begun
Three years ago, in 2015, the hemp-derived CBD market racked up $90 million in
sales. Last year that number reached $190 million in
sales — and the boom has just begun.
The Hemp Business Journal projects
$2.1 billion in total CBD sales by 2020 and estimates that $450 million of that
will come from hemp-based sources. The explosive demand projections are
attributed to an increased public awareness of the wide-ranging potential health
benefits of hemp CBD oil and advancements in cultivation, plus the convenience
and reach of online retailing — all of which contribute to a global CBD oil
market expected to grow at an
eye-popping CAGR of 39.19 percent
through 2021.
Hemp Focus
With an overarching
focus on the cultivation, development and distribution of legal industrial
hemp-derived products,
Marijuana Company of America (OTC: MCOA) aims to capture an
outsized share of growing worldwide demand. Pure hemp-based consumer nutritional
products are at the core of this demand, and the company has developed a
portfolio of ancillary hemp-centric businesses to vertically integrate hemp
production and sales. Cultivation of high-quality hem p from portfolio companies
feeds MCOA’s proprietary CBD-based formulations, dovetailing to produce the
finest quality nutritional supplements on the market.
The unique company vision emanates from Donald Steinberg, MCOA’s CEO. A
cannabis industry pioneer, he founded the first cannabinoid-centric company to
trade on a U.S. stock market. His vast knowledge and industry experience give
MCOA unparalleled insights into the machinations of the CBD markets and the
vision to capitalize on industry opportunities in a market projected to exceed
$2 billion in the coming years. In keeping with this ambitious strategy,
Steinberg and his partner, Charlie Larsen, formed Marijuana Company of America
as well its sister company, Canadian-based Global Hemp Group, Inc., which is
focused on the legal cultivation and processing of industrial hemp. MCOA
continues to build an impressive portfolio of synergistic companies across the
hemp spectrum. From farm to finished products, MCOA’s socially conscious
strategy is to capitalize at each profit point and establish a significant
footprint at multiple inflection points across the entire hemp value chain.
Hemp-Based Nutritionals
MCOA has worked to create a recognized and respected hempSMART product line
that contains levels of clinically researched ingredients designed to exceed
consumer expectations and support the body’s natural endocannabinoid system. To
serve health-conscious consumers, hempSMART includes an array of proprietary
nutritional products.
Ø
hempSMART Brain is a
patent-pending formulation designed for optimal brain function support.
Ø
hempSMART Drops offer
the highest concentration and potency of full-spectrum bioavailable CBD.
Ø
hempSMART Pain
Capsules contain a blend of premium CBD and botanical supplements.
Ø
hempSMART Pain Cream
is a proprietary formulation for relief from muscle and joint pain.
Ø
hempSMART Full
Spectrum Pet Drops is a unique nutritional supplement designed for furry
family members.
Ø
hempSMART Face is a
topical face moisturizer that combines CBD oil with ayurvedic herbs and
botanicals.
MCOA’s hempSMART goes through
an exacting CO2 extraction process to ensure the highest quality in the
company’s natural wellness product line. By combining these pure industrial
hemp-based cannabinoids with some of nature’s most effective wellness
ingredients, MCOA’s hempSMART products are poised to deliver optimally
formulated wellness products to health-conscious consumers.
In a forward-thinking plan to expand retail distribution and capitalize on
impulse buys in high-traffic stores, MCOA took a 25 percent equity stake in
BeniHemp-branded CBD products. BeniHemp health-focused products include topicals,
tinctures and edibles packaged in one-day, two-day and thirty-day supplies
widely distributed to convenience stores, smoke shops, gas stations and small
retail outlets.
A Growing Portfolio
In addition to the hempSMART and BeniHemp consumer products lines, MCOA
continues to strategically assemble synergistic portfolio companies. In a joint
venture with sister company Global Hemp Group, MCOA launched a 125-acre
industrial hemp cultivation project in northeast New Brunswick, Canada. The
project targets the promotion of hemp farming while providing year-round jobs in
crop and finished product processing.
Also in conjunction with Global Hemp Group, MCOA is developing Covered Bridge
Acres, an innovative high-yielding CBD hemp cultivation project in Oregon. The
project utilizes both traditional outdoor cultivation and what will ultimately
become more than 19,000 square feet of indoor greenhouses, which are slated to
eventually supply the raw oil needed for the hempSMART CBD product line.
MCOA also took a 15 percent equity stake in MoneyTrac Technology, Inc., a
subsidiary of Global Payout, Inc. . MCOA made this investment to help establish
and market MoneyTrac Technology as an alternative banking solution for the
cannabis industry.
Others Vying for Position
Isodiol International, Inc. (CSE:ISOL) (OTCQB:ISOLD) (FSE:LB6A.F)
grows and harvests hemp on an industrial scale then processes it to extract the
cannabidiol for distribution. The company commercializes
pharmaceutical-grade cannabinoids, micro-encapsulations and nanotechnology for
consumable and topical skin care products. Isodiol has announced plans to
develop additional over-the-counter and pharmaceutical drugs, expand its
phytoceutical portfolio and expand into Latin America, Asia and Europe.
CV Sciences, Inc. (OTCQB:CVSI) operates in two business segments. The
company’s drug development division develops and commercializes novel
therapeutics utilizing synthetic CBD. Its consumer product division
manufactures, markets and sells plant-based CBD products to a range of market
sectors. The company is also developing and pursuing FDA approval for drugs with
specific indications utilizing cannabidiol as the active pharmaceutical
ingredient.
Founded by MCOA CEO Donald Steinberg in 2009, Medical Marijuana, Inc. (OTC:MJNA)
was the first U.S.-traded CBD company. The company develops, distributes and
sells hemp oil that contains naturally occurring cannabinoids, including CBD.
The company sells its hemp-derived CBD products through a variety of
distribution subsidiaries. The company was among the first to bring hemp-based
CBD oil products to market in the United States and the first to receive federal
government import approvals in Mexico, Paraguay and Brazil.
PotNetwork Holdings, Inc. (OTC:POTN) is a publicly traded company that
acts as a holding company for its subsidiaries, First Capital Venture Co.;
Diamond CBD, Inc.; and Sunrise Auto Mall, Inc. Diamond CBD focuses on the
research, development and multinational marketing of hemp extracts that contain
a broad range of cannabinoids and natural hemp derivatives. Diamond CBD’s team
consists of hemp industry professionals, chemists, doctors and scientists — all
working together to produce CBD oils.
Seismic Shift
Modern science has begun to substantiate both the anecdotal history
and the therapeutic efficacy of cannabidiol. The FDA’s recent approval of a
cannabis-based drug represents a seismic shift and is further indication of the
enormous curative potential that may be found in CBD. As more scientific
validations ensue, the market for CBD products could easily exceed expectations,
and well-positioned companies in the space could outperform the market.
For more
information about Marijuana Company of America, please visit
Marijuana Company
of America (OTC:MCOA).
About
CannabisNewsWireCannabisNewsWire
(CNW) is an information service that provides (1) access to our news
aggregation and syndication servers, (2)
CannabisNewsBreaks
that summarize corporate news and information, (3) enhanced press release
services, (4) social media distribution and optimization services, and (5) a
full array of corporate communication solutions. As a multifaceted financial
news and content distribution company with an extensive team of contributing
journalists and writers, CNW is uniquely positioned to best serve private and
public companies that desire to reach a wide audience of investors, consumers,
journalists and the general public. CNW has an ever-growing distribution network
of more than 5,000 key syndication outlets across the country. By cutting
through the overload of information in today’s market, CNW brings its clients
unparalleled visibility, recognition and brand awareness. CNW is where news,
content and information converge.
Receive Text Alerts from CannabisNewsWire:
Text "Cannabis" to 21000
For more
information please visit
https://www.CannabisNewsWire.com
and or
https://CannabisNewsWire.News
Please see full terms of use and disclaimers on the CannabisNewsWire website
applicable to all content provided by CNW, wherever published or re-published:
http://CNW.fm/Disclaimer
DISCLAIMER:
CannabisNewsWire (CNW) is the source of the Article and content set forth above.
References to any issuer other than the profiled issuer are intended solely to
identify industry participants and do not constitute an endorsement of any
issuer and do not constitute a comparison to the profiled issuer. FN Media Group
(FNM) is a third-party publisher and news dissemination service provider, which
disseminates electronic information through multiple online media channels. FNM
is NOT affiliated with CNW or any company mentioned herein. The commentary,
views and opinions expressed in this release by CNW are solely those of CNW and
are not shared by and do not reflect in any manner the views or opinions of FNM.
Readers of this Article and content agree that they cannot and will not seek to
hold liable CNW and FNM for any investment decisions by their readers or
subscribers. CNW and FNM and their respective affiliated companies are a news
dissemination and financial marketing solutions provider and are NOT registered
broker-dealers/analysts/investment advisers, hold no investment licenses and may
NOT sell, offer to sell or offer to buy any security.
The Article and content related to the profiled company represent the personal
and subjective views of the Author, and are subject to change at any time
without notice. The information provided in the Article and the content has been
obtained from sources which the Author believes to be reliable. However, the
Author has not independently verified or otherwise investigated all such
information. None of the Author, CNW, FNM, or any of their respective
affiliates, guarantee the accuracy or completeness of any such information. This
Article and content are not, and should not be regarded as investment advice or
as a recommendation regarding any particular security or course of action;
readers are strongly urged to speak with their own investment advisor and review
all of the profiled issuer's filings made with the Securities and Exchange
Commission before making any investment decisions and should understand the
risks associated with an investment in the profiled issuer's securities,
including, but not limited to, the complete loss of your investment.
CNW & FNM HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains "forward-looking statements" within the meaning of Section
27A of the Securities Act of 1933, as amended, and Section 21E the Securities
Exchange Act of 1934, as amended and such forward-looking statements are made
pursuant to the safe harbor provisions of the Private Securities Litigation
Reform Act of 1995. "Forward-looking statements" describe future expectations,
plans, results, or strategies and are generally preceded by words such as "may",
"future", "plan" or "planned", "will" or "should", "expected," "anticipates",
"draft", "eventually" or "projected". You are cautioned that such statements are
subject to a multitude of risks and uncertainties that could cause future
circumstances, events, or results to differ materially from those projected in
the forward-looking statements, including the risks that actual results may
differ materially from those projected in the forward-looking statements as a
result of various factors, and other risks identified in a company's annual
report on Form 10-K or 10-KSB and other filings made by such company with the
Securities and Exchange Commission. You should consider these factors in
evaluating the forward-looking statements included herein, and not place undue
reliance on such statements. The forward-looking statements in this release are
made as of the date hereof and CNW and FNM undertake no obligation to update
such statements.
CannabisNewsWire (CNW) & NetworkNewsWire (NNW) are proud to be affiliated
partners of the Investor Brand Network (IBN)
About IBN
Over
the past 10+ years we have consistently introduced new network brands, each
specifically designed to fulfil the unique needs of our growing client base and
services. Today, we continue to expand our branded network of highly influential
properties, leveraging the knowledge and energy of specialized teams of experts
to serve our increasingly diversified list of clients.
Please feel free to visit the Investor Brand Network (IBN)
http://www.InvestorBrandNetwork.com
Corporate Communications Contact:
CannabisNewsWire (CNW)
Denver,
Colorado
www.CannabisNewsWire.com
303.498.7722
Office
Editor@CannabisNewsWire.net
Media Contact:
FN Media Group,
LLC
NNW@FinancialNewsMedia.com
+1-(954)345-0611
News Source:
CannabisNewsWire
MARIJUANA COMPANY OF AMERICA
AND GLOBAL HEMP GROUP PROVIDE UPDATE ON OREGON HEMP CBD FARMING PROJECT
ESCONDIDO, CA -- July 31, 2018 -- MARIJUANA COMPANY OF
AMERICA INC. (OTC: MCOA)
("MCOA" or the "Company"), an innovative hemp and cannabis corporation, and
its joint venture partner Global Hemp Group Inc. (CSE: GHG / OTC: GBHPF /
FRANKFURT: GHG) (the “Partners”) are pleased to provide an update on their high
yielding CBD hemp farming project in Scio, Oregon (the “Project”).
The 2018 hemp cultivation at the Scio, Oregon farm, operating under the name
Covered Bridge Acres (CBA),
is well underway. Although field work at the project started later than expected
due to delays in closing of the farm acquisition and various personnel changes,
our highly experienced team was able to complete two and a half months of field
prep in just four weeks. As a result, approximately 40,000 high CBD yielding
hemp plants were planted on the lower two fields of the farm, on approximately
33 acres. Six different high CBD yielding hemp cultivars were planted this year
and are progressing very well. Half of the cultivars planted were clones and the
other half were grown from seeds and were planted when they were approximately
two feet high. The results of these cultivars will be measured at harvest time
to determine the best yields and planting strategy for next season. 
With the planting now complete, our team of seven full time staff has now turned
their focus to completing the construction of the five greenhouses that were
acquired earlier in the year. Once assembled, the project will have more than
19,000 sq. ft. of active greenhouse space for research and clone production for
the 2019 planting season, which will expand to a minimum of 70 acres directly on
the CBA property, and the potential year-round harvest as the project continues
to expand its greenhouse space going forward. In addition, many neighboring
farms have expressed interest in growing hemp. Management is looking at ways to
either partner with or contract them, similar to the model being used on the
Partner’s 125-acre New Brunswick hemp farming project.
There have been a number of changes recently on the Scio project. Jeffrey Ward
has joined the team as the new Farm/Project Manager, replacing TTO Enterprises
Inc. The Partners acquired TTO’s 15% interest in the project for $30,000,
increasing their respective interest in the project to 50% each, and have
canceled the issuance of shares and warrants associated with the further
acquisition of TTO’s interest, per the original Joint Venture Agreement. Going
forward, all funding and profit sharing will be done on a 50/50 basis between
MCOA and GHG.
Mr. Ward has relocated from Auburn, Maine to be the on-site Project Manager. He
has decades of cannabis and hemp cultivation experience and has successfully
operated in the Maine Medical Marijuana program over the last decade. Doing
business as “Wicked Good Weed Company”, he was part of the design and building
of more than 100 cultivation operations ranging in size from 1,000 to 50,000 sq.
ft. He is experienced with most grow methodologies, from dirt to advanced
non-soil systems. He has experience in cross breeding, has knowledge of cloning,
nutrient scheduling, plant “first-aid”, environmental control systems,
harvesting, curing/drying, pest control, and is experienced in many extraction
methods.
In addition, he has approximately 10 years of experience as a contracted project
manager throughout Massachusetts and Maine for various industrial companies. He
has managed projects with crew sizes up to 100 workers at Harvard College, the
City of Brockton and Maine Yankee Nuclear Power Plant. He has been the lead
contact with E.P.A., D.E.P. and O.S.H.A. and was the Safety Director for temp
agencies providing workers to these projects. Mr. Ward is an outstanding
addition to lead the Scio project.
Along with Mr. Ward, joining the team are Leo and Paul Mulkey, local fourth
generation independent farmers who have provided the necessary heavy farming
equipment and field preparation services to the project. This has enabled
Covered Bridge Acres to successfully transform the lower section of the farm
from an overgrown, unusable field, to a modern, professional and productive
working farm with 40,000+ high yielding hemp plants growing.
The Mulkeys have been growing industrial hemp since 2016. In their first year of
hemp cultivation, they had the largest crop in the State of Oregon, at 75 acres.
On their farm of nearly 2,300 acres in Central Oregon, they currently grow
Industrial Hemp, Annual Ryegrass, Fescue, Meadowfoam, Phacelia, Radish, Clover,
Wheat, and Straw. Last year they shipped over 2.5 million pounds of grass seed
from their seed cleaning and warehouse facility.
With the planting operation now complete, the Mulkeys will continue to provide
consulting on harvesting and processing strategies, as well as field preparation
for the 70 farmable acres on the CBA property, as well as neighboring contracted
acres for the 2019 growing season.
Another recent addition to the team is Anthony Rushford, a hemp breeder with
over 20 years of genetics and breeding experience and author of, The Amazing
Benefits of Hempseed: Why You Should Grow Your Own Organic Hemp Seeds. Mr.
Rushford has been providing consulting services to the project, in the areas of
genetics, plant health, and the process of drying through to extraction.
His experience in a number of large scale hemp cultivation projects and
extensive extraction experience in the cannabis industry has been very helpful
to the project. Through his breeding activities he has developed over 200 high
CBD, low THC genetics, and is currently focusing on hemp and cannabis genetics,
processing and product formulations with industrial hemp derived compounds. He
has supplied genetics for research to a number of universities in the United
States and Australia, as well as supplying 20,000 high CBD hemp plants grown
from seed for the CBA Scio project. Mr. Rushford will continue to provide
ongoing consulting services to the project.
GBH Group LLC (GBH) has also been providing consulting services and have
supplied the 20,000 clones to Covered Bridge Acres. GBH Group LLC carries over
13 years of proven experience in Cannabis farming techniques, tissue culturing,
genomics, and propagation practices that have revolutionized the way industrial
hemp is being grown in the 21st century. GBH Group consults with start-up
companies across the nation in staffing, land acquisitions, and licensing to
help them get off the ground quickly and efficiently. GBH is also provide
ongoing consulting services on farm operations, genetics and greenhouse
operations.
Previously the Company announced the formation of an Escrow Pool in conjunction
with the signing of a Joint Venture Agreement between MCOA and GHG (see news
release of May 9, 2018), with the purpose of incentivizing the Oregon staff and
consultants for the successful development and maximization of shareholder value
in the Scio Hemp Project. The terms of this Escrow Pool have been changed. While
the milestones for escrow release remain the same (50% release on CBA generating
US$1.0 mil EBITDA, with the balance released on CBA’s EBITDA reaching US$2.0
mil), the number of shares and share purchase warrants have been reduced, and
the participants have changed. GHG will now be depositing to the Escrow Pool
2,300,000 common shares of GHG and 2,300,000 common share purchase warrants
exercisable at a price of CDN$0.36 per common share for a period of three years,
with MCOA depositing 10,120,000 of its common shares and 10,120,000 common share
purchase warrants exercisable at a price of USD$0.083 per common share for a
period of three years. Jeff Ward, Leo Mulkey, Paul Mulkey, Anthony Rushford, GBH
Group LLC and Matthew Calkins, CBA Farm Foreman have been added to the Escrow
Pool and TTO Enterprises has been removed.
The management team is in the process of evaluating harvesting, drying, storage
and processing strategies in preparation for the late September, early October
harvest. The Partners have guaranteed offtake agreement offers and are
evaluating the profit models of selling the biomass in bulk to processors versus
joint venturing with consulting partners to construct facilities for drying and
partnering with processors to market and distribute processed oils in the open
market.
About Marijuana Company of America, Inc.
MCOA is a corporation which participates in: (1) product research and
development of legal hemp-based consumer products under the brand name
“hempSMART™”, that targets general health and well-being; (2) an affiliate
marketing program to promote and sell its legal hemp-based consumer products
containing CBD; (3) leasing of real property to separate business entities
engaged in the growth and sale of cannabis in those states and jurisdictions
where cannabis has been legalized and properly regulated for medicinal and
recreations use; and, (4) the expansion of its business into ancillary areas of
the legalized cannabis and hemp industry, as the legalized markets and
opportunities in this segment mature and develop.
About Global Hemp Group Inc.
Global Hemp Group Inc. (CSE: GHG) (OTC: GBHPF) (FRANKFURT: GHG), is
headquartered in Vancouver, British Columbia, Canada, with base operations in
Montreal and Los Angeles. The Company is focused on a multi-phased strategy to
build a strong presence in the industrial hemp industry in both Canada and the
United States. The first phase of this strategy is to develop hemp cultivation
with the objective of extracting cannabinoids (CBD, CBG, CBN & CBC) and creating
a near term revenue stream that will allow the Company to expand and develop
successive phases of the strategy. The second phase of the plan will focus on
the development of value-added industrial hemp products utilizing the processing
of the whole hemp plant, as envisioned in the Company’s Hemp Agro-Industrial
Zone (HAIZ) strategy.
Forward Looking Statements
This news release contains "forward-looking statements" which are not purely
historical and may include any statements regarding beliefs, plans, expectations
or intentions regarding the future. Such forward-looking statements include,
among other things, the development, costs and results of new business
opportunities and words such as "anticipate", "seek", intend", "believe",
"estimate", "expect", "project", "plan", or similar phrases may be deemed
"forward-looking statements" within the meaning of the Private Securities
Litigation Reform Act of 1995. Actual results could differ from those projected
in any forward-looking statements due to numerous factors. Such factors include,
among others, the inherent uncertainties associated with new projects, the
future U.S. and global economies, the impact of competition, and the Company's
reliance on existing regulations regarding the use and development of
cannabis-based products. These forward-looking statements are made as of the
date of this news release, and we assume no obligation to update the
forward-looking statements, or to update the reasons why actual results could
differ from those projected in the forward-looking statements. Although we
believe that any beliefs, plans, expectations and intentions contained in this
press release are reasonable, there can be no assurance that any such beliefs,
plans, expectations or intentions will prove to be accurate. Investors should
consult all of the information set forth herein and should also refer to the
risk factors disclosure outlined in our annual report on Form 10-12G, our
quarterly reports on Form 10-Q and other periodic reports filed from
time-to-time with the Securities and Exchange Commission. For more information,
please visit www.sec.gov.
For more information, please visit the Company’s websites at:
www.MarijuanaCompanyofAmerica.com
www.hempSMART.com
NetworkNewsWires/MCOA
Corporate Communications Contact:
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com
Source: Marijuana Company of America, Inc.
Proposed Legal Changes Offer a
Boost for Cannabidiol Companies in the United States
New York, NY – July
25, 2018 –
CannabisNewsWire.com News Coverage:
Recent growth in the market
for cannabidiol (CBD) products has been strong and appears poised to continue.
·
CBD is an active
ingredient derived from industrial hemp that does not contain the
psychoactive or “high” effect of marijuana.
·
CBD is used in a wide
range of products, from cosmetics to pet supplements.
·
The recent acceptance of a
CBD-based medicine by U.S. authorities creates potential for legal change
that could make the sale of CBD easier.
·
Attention in the
mainstream press has created a measure of gravitas for CBD.
Marijuana Company of America Inc. (OTC:MCOA)
has produced a diverse range of CBD products to promote well-being. Cannabis
company Canopy Growth Corp. (NYSE:CGC) has created a range of CBD oils
for its
customers
while expanding its global reach. Aurora Cannabis, Inc. (OTC:ACBFF)
provides pain relief through a range of cannabis strains and is set to expand
its R&D potential through a takeover. Terra Tech Corp. (OTC:TRTC)
provides equipment to cultivate cannabis and would benefit from a change in the
legal landscape alongside its customers. PotNetwork Holding, Inc. (OTC:POTN)
holds several subsidiary companies benefiting from cannabis and CBD products,
thanks to the diversity of the sector.
U.S. Authorities Consider Legal Changes
For decades, federal rules have
held back cannabinoid-derived medicines in the United States. Though the
majority of states now allow medical marijuana and associated cannabinoid-derived
products, national legislation is still grounded in the war on drugs. The
cannabis and hemp plants are classified as a Schedule I drug, meaning that it is
legally seen as both dangerous and without medical benefits. Even treatments
using cannabidiol (CBD), an active ingredient found in hemp and cannabis that is
nonpsychoactive, currently fall under this classification.
That may be about to change.
Following the Food and Drug Administration’s (FDA) ground-breaking acceptance of
prescription drug Epidiolex, the future of CBD products for medicinal use
appears to be up in the air. Meanwhile, legislation from both sides of America’s
political divide offers the possibility of bigger changes.
Tackling the Law
Progress on the legal status of
CBD is being eagerly watched by companies such as
Marijuana Company of America Inc. (OTC:MCOA).
With a focus on industrial hemp and hemp-derived cannabidiol products, MCOA
doesn’t produce and sell medical or recreational marijuana. But because hemp
products are derived from the same family of plants, they fall under the same
stigmas associated with the plant.
Increasingly liberal
legislation at the state level has allowed companies such as MCOA to thrive in
the United States. But that evidence-based liberalization is in conflict with
the federal government’s decades-long prohibition, which some within the current
conservative government are looking to reinforce rather than relax. 
Despite this, the FDA
approved CBD-based
Epidiolex
in June.
Epidiolex has been developed to counter the
seizures brought on by two rare ailments. Its approval for sale as a
prescription medicine doesn’t mean that similar medications will automatically
be approved, but it does open the possibility. In light of the approval,
repeated calls have been made for the FDA to look again at the scheduling of
certain cannabinoids and the broader picture of cannabis-derived medicines.
At the same time, several
pieces of legislation that could change CBD’s status
are being considered by
Congress.
Some of those are actually being proposed by Republicans, making it appear less
likely that they will be blocked by America’s more conservative party. It looks
increasingly likely that rescheduling or other legislative changes may soon make
it easier for companies to cultivate industrial hemp as well as produce and
market CBD products.
When such change comes,
companies with a wide array of products are likely to be the ones that will
benefit most. With a range that already runs from pain treatment to therapies
for pet care and memory enhancement, MCOA’s line of products is representative
of how versatile the use of CBD can be. A loosening of restrictions would make
it easier to both broaden this selection and make it available to a wider
market.
CBD Goes Mainstream
The growth of companies such as
Marijuana Company of America Inc. (OTC:MCOA)
is helped by increasing mainstream attention on CBD.
Forbes has reported on
research into the product by the World Health Organization.
Esquire has profiled
the rise and diverse uses of this ingredient.
The Washington Post has
explored
the growing popularity of CBD among celebrities, consumers and wellness
professionals.
Because CBD doesn’t get a user
high, it might seem strange that the marijuana derivative is becoming one of the
most popular hemp-derived products. But the wellness market is big business in
America as consumers clamor for ways to improve their energy levels and reduce
the low-key aches and pains of everyday life. CBD’s reputation for improving
health is making it popular among people who want the reported medical benefits
without having to deal with the high.
The result is a fast-growing
market. Consumer sales of CBD amounted to
$262.2 million in the
United States in 2016,
more than double what they had been only two years before. Based on the market’s
ongoing growth, analysts have predicted that the market will
hit the billion-dollar
mark by 2021.
More than half of CBD consumers take the products every day
with anxiety, anti-inflammation and joint pain being the top symptoms the
products are designed to impact. Successful treatment of these conditions would
likely create a large base of long-term consumers.
The Varied Uses of CBD
This large and growing
consumer base is looking to CBD for potential impact on a wide range of wellness
concerns. The ability of companies such as MCOA to provide a range of
products aimed at these symptoms would allow those
companies to tap into a broad share of the market. MCOA’s hempSMART™ products
are a great example of how many uses a single company can find for CBD.
HempSMART Brain is
a patent-pending nootropic product designed to
support natural brain function, which fits with what many consumers
expect from CBD because the product is focused on the mind. These innovative
capsules can be taken to support alertness and concentration.
HempSMART Pain is
designed to provide relief from pain associated with physical activity by
combining CBD with botanical supplements. Their hempSMART Pain Cream
is designed to provide temporary relief from and
soothe sore, aching muscles and joints.
The company most recently launched a new cosmetic product, hempSMART Face, a CBD
facial moisturizer that has been designed to refresh, replenish and restore skin
cells on the face. And perhaps most surprising
is the company’s offering of sublingual CBD
tinctures, including hempSMART Full-Spectrum Drops and hempSMART Pet
Drops, a bacon-flavored supplement formulated to provide cats and dogs with
renewed energy as well as a tasty treat.
Such a diverse range
of products could help a company such as MCOA attract the attention of
CBD consumers. It might also allow consumers to use CBD in more areas of their
lives, expanding the CBD market.
Companies Set to Benefit
It’s not just the variety of
CBD products that bodes well for the industry — it’s also the range of
companies. If the legal status of cannabis and cannabis-derived products
changes, an entire sector is set to benefit.
Canopy Growth Corp.
(NYSE:CGC), a leading player
in retail cannabis, is using its research in the area to create CBD oils. By
balancing the ratio of CBD and THC within its oils, Canopy Growth caters to
differing wellness needs. Already a trusted player within the Canadian market,
the company has
acquired a
subsidiary in the Kingdom of Lesotho
and
established another in Latin America.
By looking to the wider world, the company is further expanding the global
market for cannabis and CBD products.
One of the leading areas of
interest for CBD is in pain relief. Aurora Cannabis, Inc. (OTCQX:ACBFF),
one of the largest cannabis companies in the world, has established a strong
position in this sector. The company has developed a
large
range of different strains of medical cannabis
that can be used in developing new products as well as in retail. The Canadian
Competition Bureau recently
approved a
takeover of
MedReleaf Corp.
,
a research-oriented company, by Aurora, leaving the company in a stronger
position to make the most of the coming changes.
Rescheduling cannabis would benefit not just the companies selling
cannabis and CBD products but also those supporting them. Terra Tech Corp.
(OTCQX:TRTC) is a producer of environmentally friendly growing systems for
cannabis growers. Its hydroponic systems use moving tables and recycled waste
water to increase yields and reduce costs. As it becomes easier to grow and
market cannabis, more growers may turn to Terra Tech for the equipment they
need.
The maturity of the CBD and
cannabis sector has also led to the emergence of several holding companies,
including PotNetwork Holding, Inc. (OTCPK:POTN). This company’s
subsidiaries include Diamond CBD, First Capital Venture and PotNetwork. Through
these entities, PotNetwork benefits from growth across different parts of the
industry, as well as supporting other companies in their expansion.
The market for CBD and other
cannabis-derived products is already strong. With the prospect of legal
rescheduling increasingly likely, these companies seem poised to benefit from
changing attitudes in the United States and beyond.
For more information about
Marijuana Company of America, please visit
Marijuana Company of America Inc. (OTC:MCOA)
About
CannabisNewsWire
CannabisNewsWire (CNW) is an information service that provides (1) access to our
news aggregation and syndication servers, (2)
CannabisNewsBreaks
that summarize corporate news and information, (3) enhanced press release
services, (4) social media distribution and optimization services, and (5) a
full array of corporate communication solutions. As a multifaceted financial
news and content distribution company with an extensive team of contributing
journalists and writers, CNW is uniquely positioned to best serve private and
public companies that desire to reach a wide audience of investors, consumers,
journalists and the general public. CNW has an ever-growing distribution network
of more than 5,000 key syndication outlets across the country. By cutting
through the overload of information in today’s market, CNW brings its clients
unparalleled visibility, recognition and brand awareness. CNW is where news,
content and information converge.
Receive Text Alerts
from CannabisNewsWire:
Text "Cannabis" to
21000
For more information please visit
https://www.CannabisNewsWire.com
and or
https://CannabisNewsWire.News
Please see full terms of use and
disclaimers on the CannabisNewsWire website applicable to all content provided
by CNW, wherever published or re-published:
http://CNW.fm/Disclaimer
DISCLAIMER: CannabisNewsWire
(CNW) is the source of the Article and content set forth above. References to
any issuer other than the profiled issuer are intended solely to identify
industry participants and do not constitute an endorsement of any issuer and do
not constitute a comparison to the profiled issuer. FN Media Group (FNM) is a
third-party publisher and news dissemination service provider, which
disseminates electronic information through multiple online media channels. FNM
is NOT affiliated with CNW or any company mentioned herein. The commentary,
views and opinions expressed in this release by CNW are solely those of CNW and
are not shared by and do not reflect in any manner the views or opinions of FNM.
Readers of this Article and content agree that they cannot and will not seek to
hold liable CNW and FNM for any investment decisions by their readers or
subscribers. CNW and FNM and their respective affiliated companies are a news
dissemination and financial marketing solutions provider and are NOT registered
broker-dealers/analysts/investment advisers, hold no investment licenses and may
NOT sell, offer to sell or offer to buy any security.
The Article and content related to the profiled company represent the personal
and subjective views of the Author, and are subject to change at any time
without notice. The information provided in the Article and the content has been
obtained from sources which the Author believes to be reliable. However, the
Author has not independently verified or otherwise investigated all such
information. None of the Author, CNW, FNM, or any of their respective
affiliates, guarantee the accuracy or completeness of any such information. This
Article and content are not, and should not be regarded as investment advice or
as a recommendation regarding any particular security or course of action;
readers are strongly urged to speak with their own investment advisor and review
all of the profiled issuer's filings made with the Securities and Exchange
Commission before making any investment decisions and should understand the
risks associated with an investment in the profiled issuer's securities,
including, but not limited to, the complete loss of your investment.
CNW & FNM HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains
"forward-looking statements" within the meaning of Section 27A of the Securities
Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as
amended and such forward-looking statements are made pursuant to the safe harbor
provisions of the Private Securities Litigation Reform Act of 1995.
"Forward-looking statements" describe future expectations, plans, results, or
strategies and are generally preceded by words such as "may", "future", "plan"
or "planned", "will" or "should", "expected," "anticipates", "draft",
"eventually" or "projected". You are cautioned that such statements are subject
to a multitude of risks and uncertainties that could cause future circumstances,
events, or results to differ materially from those projected in the
forward-looking statements, including the risks that actual results may differ
materially from those projected in the forward-looking statements as a result of
various factors, and other risks identified in a company's annual report on Form
10-K or 10-KSB and other filings made by such company with the Securities and
Exchange Commission. You should consider these factors in evaluating the
forward-looking statements included herein, and not place undue reliance on such
statements. The forward-looking statements in this release are made as of the
date hereof and CNW and FNM undertake no obligation to update such statements.
CannabisNewsWire (CNW) & NetworkNewsWire (NNW) are proud to be affiliated
partners of the Investor Brand Network (IBN)
About IBN
Over the past 10+ years we have consistently introduced new network brands,
each specifically designed to fulfil the unique needs of our growing client base
and services. Today, we continue to expand our branded network of highly
influential properties, leveraging the knowledge and energy of specialized teams
of experts to serve our increasingly diversified list of clients.
Please feel free to visit the Investor Brand Network (IBN)
http://www.InvestorBrandNetwork.com
Corporate Communications Contact:
CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net
Media Contact:
FN Media Group, LLC
NNW@FinancialNewsMedia.com
+1-(954)345-0611
News Source: CannabisNewsWire
-------------------------------------------------------------------
About Marijuana Company of America, Inc.:
Marijuana Company of America (OTC: MCOA) offers investors the opportunity to be
on the forefront of innovation in the legal cannabis and industrial hemp
industries. We strive to produce a diverse portfolio of synergistic companies
that provide value to our shareholders. Our vertically integrated business model
provides our company’s and partnerships the best position for rapid growth.
Turn-key facilities will provide individuals with only the highest quality
ingredients that ensures our costumer’s loyalty, where our distribution
platform, hempSMART™, is strongly positioned to capture market share by
developing recognizable brands through unique ways to promote to individuals.
Marijuana Company of America Inc. was established as a publicly traded company
“MCOA” in 2015 by Don Steinberg and Charles Larsen, two veterans of the cannabis
and industrial hemp industries. Their goal was to capture a piece of the $6.7
billion cannabis and $688 million hemp industries which have been enjoying
exponential growth with no slowdown in sight.
The objective is to create an umbrella under which we would place a variety of
portfolio companies that participate within this industry. Taking on a long term
vision and recognizing the many potential opportunities that exist, we have
established ourselves along various points in the cannabis, industrial hemp, and
related services supply chain.
Our wholly owned subsidiary hempSMART™ delivers all of the benefits of
industrial hemp derived cannabinoid (non THC) products to the world through its
unique marketing and distribution platform. MCOA, also, provides turn-key
services to the legal cannabis and hemp industry, as well as, strategically
investing in synergistic companies to develop a diverse portfolio of
subsidiaries and joint ventures that create value for our shareholders.
As MCOA embarks on its 2nd year, we find ourselves with many new partners, joint
venture relationships, and a very powerful consortium of companies who share our
global vision.
We are in the right business, at the right time, with the right experience to
take this company to the next level.
MCOA is publicly traded on OTC Markets under symbol MCOA.
We are building a portfolio of investments and joint ventures that represent the
highest integrity and professionalism in the legal cannabis and industrial hemp
markets. MCOA will be a model for entrepreneurs and businesses that share our
common goals and philosophies of not only creating value for investors, but also
creating an environment for businesses to improve the quality of life of our
customers through healthy, sustainable alternatives to many products currently
on the market.
Become hempSMART
HempSMART™ is a company with a mission of educating and empowering consumers to
learn about and become part of the Hemp Movement. This includes consuming and
benefiting from some of the world’s most innovative hemp product technologies
created by hempSMART.
Our mission is to make potential consumers “hempSMART.” Seeing the wellness
environment rapidly shifting regarding premium quality cannabinoid products, the
hempSMART founders have selected key professionals for various roles on the
hempSMART team. This includes many of the best wellness professionals, health
professionals, product formulation experts, educators, marketers and business
minds to ensure that hempSMART can place you in a “first to market” position in
every way.
The products are only the beginning.
Those that join the hempSMART Mission can start improving their personal
wellness from day 1 with hempSMART products as well as become involved in this
rapidly emerging industry with unlimited potential in the marketplace. Our
product philosophy is to provide consumers with the newest, most innovative
products, research and delivery systems related to hemp and CBD based products
to improve their personal wellness.
HempSMART also provides a low barrier to entry business opportunity for
entrepreneurs in a rapidly emerging, global marketplace.
HempSMART is is about to become a major industry brand with global operations
providing wellness and opportunity for potentially millions of people.
Joint Venture
Pursuant to the joint venture, Marijuana Company of America, Inc. is committed
to raising up to one (1) million dollars in funding provided to Bougainville
Ventures to construct and manage a turnkey state of the art cultivation and
processing facility in Oroville, Washington. The 30,000 sq.ft. greenhouse grow
will house a Tier-3 production and processing I-502 tenant with decades of
experience in high yields, consistency and quality.
MCOA will provide investors updates as the project progresses. MCOA management
is in negotiations on deals with similar terms in other legal MMJ states.
The Focus
Bougainville Ventures Inc. (Bougainville) is an agricultural services company
that focuses on providing growers with state-of-the-art computer controlled
greenhouses and processing facilities. Our clients can focus on expanding their
market share with minimal capital investment. We create solutions for our
tenant-grower partners to become their primary growing infrastructure or to
expand the bandwidth of their current farming infrastructure. Bougainville
intends to offer fully built out turnkey solutions to licensed I-502
tenant-growers and luxury crop growers who will lease the facilities for
production and processing.
A Re-Defined Network / The All-In-One Solution
MoneyTrac Technology, Inc. is a majority owned subsidiary of Global Payout, Inc.
and is a pioneer in offering a full-service solution for alternative banking and
electronic financial solutions.
MoneyTrac provides all aspects of financial technology including E-Wallet and
mobile apps services for businesses and companies in various “high-risk”
industries.

MoneyTrac’s technology platform allows for its clients to access their financial
information from anywhere in the world, in addition to providing tracking and
compliance to help them manage and control the flow of all revenue through their
business.
With the legalization of cannabis sweeping the nation, financial compliance is a
big factor toward obtaining licensing for various sectors of this industry.
“The electronic payment and compliance features available through the MTT
technology platform are the solutions many sectors of our Cannabis industry have
been looking for, and I look forward to providing the MTT Board with guidance
and support to help move their objectives forward in the most effective way
possible,” said Mr. Steinberg MCOA CEO.
MCOA intends to invest $250,000 in exchange for 15% of MTT, a subsidiary of
Global Payout (OTC: GOHE).
Joint venture with GateC Research
Pursuant to the joint venture with GateC Research (“GRC”), MCOA is committed to
raising million dollars to fund joint venture operations. This joint venture is
for the purpose of cultivation, processing and distribution of legal cannabis
within the state of California. GRC has successfully managed multiple legally
compliant cultivation projects in multiple states, with their expertise we can
expect state of the art facilities that produce high returns.
By replicating our production and processing model in California, the 6th
largest economy in the world, MCOA has the opportunity to expand operations
significantly.
Marijuana Company of America (MCOA) and Global Hemp Group (GHG) are launching
agricultural hemp trials in northeast New Brunswick. It marks the return of
industrial hemp to the region where it was tried 20 years ago but failed to take
off due to lack of market opportunities. These trials are part of the first of
three phases in implementing the Company’s Hemp Agro-Industrial Zone (HAIZ). The
project focuses on the development of an industrial cluster around the hemp
crop, which will ensure a market for farmers, year-round manufacturing job
opportunities for the region, and a model for the Company to attract and develop
additional HAIZ projects in other regions as well as provide a consistent
potential revenue stream for both the MCOA and GHG shareholders.
Space Cowboys operates boutique and specialized lawful hemp farms in the state
of Colorado for the primary purpose of Cannabinoid research, production and
sales. Space Cowboys’ operations are in full compliance with Colorado state law
and holds two licenses with the Colorado Department of Agriculture. Space
Cowboy’s farms are up to date with all Department of Agriculture required
filings, testing, and reporting. SC farms cultivate with minimal pesticides and
uses only those pesticides approved by the Colorado Department of Agriculture.
SOURCE: http://marijuanacompanyofamerica.com/
Disclaimer
FN Media Group LLC (FNMG) owns and operates
FinancialNewsMedia.com (FNM)
which is a third party publisher that disseminates electronic information
through multiple online media channels. FNMG's intended purposes are to deliver
market updates and news alerts issued from private and publicly trading
companies as well as providing coverage and increased awareness for companies
that issue press to the public via online newswires. FNMG and its affiliated
companies are a news dissemination and financial marketing solutions provider
and are NOT a registered broker/dealer/analyst/adviser, holds no investment
licenses and may NOT sell, offer to sell or offer to buy any security. FNMG's
market updates, news alerts and corporate profiles are NOT a solicitation or
recommendation to buy, sell or hold securities. The material in this release is
intended to be strictly informational and is NEVER to be construed or
interpreted as research material. All readers are strongly urged to perform
research and due diligence on their own and consult a licensed financial
professional before considering any level of investing in stocks. The companies
that are discussed in this release may or may not have approved the statements
made in this release. Information in this release is derived from a variety of
sources that may or may not include the referenced company's publicly
disseminated information. The accuracy or completeness of the information is not
warranted and is only as reliable as the sources from which it was obtained.
While this information is believed to be reliable, such reliability cannot be
guaranteed. FNMG disclaims any and all liability as to the completeness or
accuracy of the information contained and any omissions of material fact in this
release. This release may contain technical inaccuracies or typographical
errors. It is strongly recommended that any purchase or sale decision be
discussed with a financial adviser, or a broker-dealer, or a member of any
financial regulatory bodies. Investment in the securities of the companies
discussed in this release is highly speculative and carries a high degree of
risk. FNMG is not liable for any investment decisions by its readers or
subscribers. Investors are cautioned that they may lose all or a portion of
their investment when investing in stocks. This release is not without bias, and
is considered a conflict of interest if compensation has been received by FNMG
for its dissemination. To comply with Section 17(b) of the Securities Act of
1933, FNMG shall always disclose any compensation it has received, or expects to
receive in the future, for the dissemination of the information found herein on
behalf of one or more of the companies mentioned in this release. For current
services performed FNMG has been compensated forty five hundred dollars for
Marijuana Company of America, Inc.. coverage by the company. FNMG HOLDS NO
SHARES OF Marijuana Company of America, Inc.
This release contains "forward-looking statements" within the meaning of Section
27A of the Securities Act of 1933, as amended, and Section 21E the Securities
Exchange Act of 1934, as amended and such forward-looking statements are made
pursuant to the safe harbor provisions of the Private Securities Litigation
Reform Act of 1995. "Forward-looking statements" describe future expectations,
plans, results, or strategies and are generally preceded by words such as "may",
"future", "plan" or "planned", "will" or "should", "expected," "anticipates",
"draft", "eventually" or "projected". You are cautioned that such statements are
subject to a multitude of risks and uncertainties that could cause future
circumstances, events, or results to differ materially from those projected in
the forward-looking statements, including the risks that actual results may
differ materially from those projected in the forward-looking statements as a
result of various factors, and other risks identified in a company's annual
report on Form 10-K or 10-KSB and other filings made by such company with the
Securities and Exchange Commission. You should consider these factors in
evaluating the forward-looking statements included herein, and not place undue
reliance on such statements. The forward-looking statements in this release are
made as of the date hereof and FNMG undertakes no obligation to update such
statements.
|